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General introduction
The impact of rheumatoid arthritis (RA) has been well described in the nineteen fifties 
in the American Journal of Bone and Joint Surgery [25]; “The patient with rheumatoid 
arthritis who has severe and generalized disease is disabled, more often than not, to the point 
of invalidism. He presents economic, social, and psychological problems of considerable 
magnitude. In many patients in this series, there was a major economic problem, sometimes 
affecting the family. One, two, or more persons are frequently required to devote full time 
to the daily care of the severe arthritic cripple. An otherwise productive member of the 
family thus loses earning capacity. Socially, the afflicted individual is unable to care for 
his own personal needs: toilet, feeding, dressing, or walking”. Until today, RA can have 
devastating consequences for the patient and its family [4, 9, 12].
Total hip arthroplasty in rheumatoid arthritis
Since the introduction of total hip arthroplasty (THA) it has been the treatment of choice in 
end-stage hip disease in osteoarthritis and rheumatoid arthritis [6, 7]. However, orthopaedic 
surgeons and referring practitioners associate RA with a decreased chance of favourable 
outcome after total hip arthroplasty compared to the results in osteoarthritis (OA) 
patients [29]. The most frequently mentioned complications are post-operative infection, 
dislocation of the prosthesis, intra-operative fractures, malpositioning of implants, and 
aseptic loosening. Several risk factors have been accounted for this alleged increased risk 
for complications. Progression of the inflammatory disease, multiple joint involvement, 
young age, jeopardized biomechanical properties of soft tissue and bone, and the anti 
rheumatoid medication are all considered as factors that could have a negative influence 
on successful outcome of THA in RA. 
Aseptic loosening of the cup has been considered as the most important factor limiting 
the long-term success of THA in RA [5, 15, 17, 18, 23, 24, 26, 33]. 
Cementless THA in RA
Cementless cups were introduced in the RA population in the search for improvement 
of the survival of the cemented cup in the nineteen eighties [8, 10, 11, 16, 31]. The idea 
of implanting cementless cups in bone with jeopardized qualities was supported by in 
vitro studies. At first, stability of press fit cups was tested in polyethylene foam cubes of 
different densities mimicking a situation with less bone quality. In the dense sawbones 
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higher resistance to compression can occur precluding the seating of the cup resulting in 
reduced stability, while this complication did not occur in the soft sawbones. The authors 
concluded that in osteopenic bone complete seating of the cup occurs resulting in a stable 
implanted cup [1]. Meanwhile radiographical research showed no difference in the changes 
of peri-articular bone after implantation of a cementless prosthesis in RA patients compared 
to the changes in OA patients [13]. Despite the short-term successes several questions 
raise on implanting cementless implants in rheumatoid bone as initial fixation depends on 
cortical and cancellous bone stiffness and strength for initial fixation. The initial fixation 
of press-fit cups is achieved by compressive and frictional forces of the acetabular cavity 
acting on the cup surface, which counter- balance the hip joint contact force [27]. This 
fixation mainly takes place by clamping of the cup in the peripheral rim of the acetabulum 
[1, 14, 19, 20, 32]. A good initial fixation, limiting interfacial micromotions, is mandatory 
to achieve bony ingrowth and proper long-term fixation [22, 28]. 
In rheumatoid arthritis the biomechanical properties of the bone are affected by the disease 
process [2, 3, 21], and the anti-rheumatic medication [30]. This loss of bone quality could 
compromise the quality of the initial fixation and lead to insufficient osseous integration. 
On top of this the risk of fractures of the acetabulum and the femur during implantation 
could be increased [3]. Not surprisingly, for decades, RA has been considered to be a 
relative contraindication for cementless fixation of implants.
Aims of the thesis
The aim of this thesis is to assess if cementless implants can be used safely in total hip 
arthroplasty in rheumatoid patients, and to assess if the use of cementless implants could 
be beneficial for the rheumatoid patient.
To investigate the aims of this thesis four research questions were formulated: (1) can we 
make a computer model to investigate the relationship between biomechanical properties 
of bone and fixation of cementless implants, and can we predict which type of fixation is 
best in relation with the quality of the bone? (2) What are the results of cementless cup 
designs (threaded and press-fit) and a cementless stem in RA patients compared to OA 
patients in our own institute, with special emphasis on four mechanical complications: 
peri-operative fracture, component migration, aseptic loosening and dislocation? (3) 
What are the results in the literature of cemented THA in RA? (4) What are the results of 
cementless THA in RA in the literature?
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Outline of the thesis
Chapter 2 gives an overview of the general considerations facing hip arthroplasty in 
rheumatoid arthritis patients, such as demographics of hip involvement in RA, history 
of surgical treatment, surgical technique, the potential complications, timing and results.
Chapter 3 reports the results of investigations with a finite element model of the pelvis. 
The fixation strength of press-fit cups in relationship to the quality of the acetabular bone 
and the geometry of the cup is investigated. 
Chapter 4 presents the long-term results of a retrospective clinical study. The study was 
performed in the Slotervaartziekenhuis, Amsterdam, Netherlands, a regional reference 
centre for the surgical treatment of inflammatory arthritis patients. Cementless THA in 
RA patients is being performed here since 1986. The results of cementless THA (with use 
of a threaded cup and a press-fit stem) in RA patients are compared to the results of the 
same prosthesis in OA patients.
In Chapter 5 a second clinical study from the Slotervaartziekenhuis is presented. In 
this study the results of a new type of press-fit acetabular component were analyzed in 
a prospective study again with a comparison between cementless THA in RA and OA 
patients.
Chapter 6 presents a third clinical study: a prospective study to analyze the alleged increased 
risk for post-operative hip dislocation in RA patients compared to OA patients. 
Chapter 7 is a review of the literature on cemented THA in RA focused on infections, 
dislocation and aseptic loosening of cup and stem.
Chapter 8 is a systematic review of the literature on cementless THA in reumatoid arthrits 
with special emphasis on complications such as peri-operative fractures, implant migration, 
aseptic loosening and survival.
Chapter 9 contains the general discussion on the role of cementless THA in reumatoid 
arthritis based on the work presented in this thesis.
Chapter 10 contains the summaries of all chapters.
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Epidemiology and incidence of hip involvement in rheumatoid arthritis
Rheumatoid arthritis (RA) is the most frequent inflammatory joint disorder with a 
prevalence of nearly 1% in adults [64, 65]. RA occurs world wide, in all climates, and affects 
all ethnic groups to varying degrees. Recent studies of rheumatoid arthritis worldwide 
suggest that prevalence of arthritis is higher in Europe and North America than in 
developing countries [3]. The average of onset in most studies is somewhat over 50 years. 
The etiology of RA remains unknown. The general opinion is that the development and 
manifestations of the disease are a result of one or more disorders in the immune system. 
The factors which cause the immune system to stimulate, react, and induce tissue damage 
are still being investigated. 
There are no disease characteristics with 100% sensitivity and specificity. That is why the 
diagnosis of RA is made on the basis of medical history, physical examination, clinical 
chemistry and immunology examinations, and radiology findings. The American College 
of Rheumatology (ACR) defined seven criteria to classify RA [5]: (1) morning stiffness in 
involved joints for at least one hour. (2) Arthritis for at least 6 weeks in three or more defined 
joints. (3) Arthritis in the joints of the hand. (4) Symmetrical arthritis. (5) Rheumatoid 
nodules. (6) Positive rheumatoid factor test. (7) Radiological changes typical for RA with 
periarticular decalcification, cartilage reduction or erosion. A clinical profile including at 
least four of the seven criteria is considered consistent with the diagnosis of RA. 
The hip joint is affected in 15% to 30% of all RA patients [29]. In the end 10 to 25 % of all RA 
patients will undergo THA [90]. During 25-yrs follow-up of a cohort of RA patients 27% of 
them needed a hip or knee replacement [102], 41% of them more than one prosthesis [69]. 
Approximately 5% of all THA in Norway and Sweden were performed in RA patients 
[37, 58]. RA patients are 10 to 15 years younger compared to OA patients at time of the 
primary THA and approximately 80% is female. 
History of surgical treatment
Before the introduction of total hip arthroplasty several surgical procedures have been 
tried over the years. To relief pain and increase mobility of an ankylotic joint, resection 
of the femoral head was an option in the beginning of the twentieth century [7, 34, 100]. 
It was early recognized that in – contrast to other joints – synovectomy and osteotomy 
did not help in the hip joint [70]. Arthrodesis was seldomly succesfull because of the 
progressive nature of the disease and the usual inevitable involvement of the other hip and 
the spine [21]. Only in selected cases arthrodesis was performed in patients with arrested 
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rheumatoid arthritis, good preservation of the remaining joints in the lower extremity and 
limited rheumatoid involvement of the contralateral hip [70]. Resection and angulation 
osteotomy was performed in ankylosing hips to improve patients’ ability to transfer from 
bed to chair but was no solution for the ambulant patient [21, 24, 62, 70]. 
The first types of arthroplasty were introduced in the second and third decade of the twentieth 
century. Smith-Petersen [82] describes a two-stage procedure with implantation of a large 
glass or bakelite loose mold cup placed over the head of the femur. The idea was that the joint 
surfaces could reshape after which the cup could be removed after one or two years. Later a 
vitallium mold cup was developed that was left in place, the acetabulum was reamed and the 
femoral head shaped to fit the proper mold [82, 84]. The surgical approach used was either 
anterior (Smith-Petersen) or lateral with an osteotomy of the trochanter. The results of this 
cup arthroplasty were good in the first years post-op but failure rates after several years were 
as high as 45% due to infection, structural failure of the mould or cup arthroplasty, fractures 
of the neck, migration, wear, absorption of the femoral head, or loss of motion [21, 24, 80, 84]. 
The resurfacing cup arthroplasty procedure was abandoned and replaced by a hemi-
arthroplasty procedure with an artificial head placed on a femoral stem. At first this was 
placed with a short femoral stem [45], later with a longer stem. These stems were usually 
inserted without cement and suffered from loosening and migration on the femoral side, 
while on the acetabular side the hemi-arthroplasty suffered from protrusio of the head 
into the non-replaced acetabulum [17, 21, 104]. 
The first promising results of standard total hip arthroplasty (THA) with a cemented stem 
and a metal ball-head articulating in a cemented polyethylene cup were reported in RA 
patients in the early nineteen-seventies [4, 21, 25, 35, 40]. 
Over the years several attempts have been made to improve the results of THA in RA 
patients such as the hemiarthroplasy with bipolar articulation [87, 88], the McKee-Farrar 
THA [4, 31], the resurfacing Wagner prostheses [89], the uncemented PE cup [57], and 
the resurfacing Bipolar double cup [75], but the results of alternative implants could not 
match the results of the standard cemented THA. This standard cemented THA has been 
for many years the treatment of choice in destructive hip disease in RA.
Complications related to hip arthroplasty in rheumatoid arthritis
Patients with RA are generally considered to be more prone to complications after hip 
replacement due to the nature of the disease with its deleterious effects on the bone and 
soft tissues, and due to the side effects of anti-rheumatic drug treatment.
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Infection
Infection in a rheumatoid patient is one of the most dangerous and frequent complications 
[10, 15, 24, 28, 33]. Increased rates of postoperative infections after THA have been 
reported in numerous studies since the introduction of the standard hip prosthesis [4, 10, 
14, 37, 59, 68, 74, 79, 81, 83]. In contrast to all these studies there is a significant number 
of publications that do not report increased infection rates and that report infection rates 
comparable with the general population after THA [23, 25, 30, 32, 46, 53, 72, 104]. The 
causes of these conflicting conclusions need to be investigated. 
Dislocation
In line with the discussion on postoperative infections, the reports on dislocation are 
contradicting as well. Some authors have reported a higher dislocation rate after THA in 
RA [6, 11, 27, 38], while other reports have shown no significant difference in dislocation 
rate between RA and osteoarthrosis [17, 39, 72, 103]. 
Fractures
THA in RA is associated with an increased risk of fractures during the surgical procedure 
[Campbell 9th edition 1998]. Perioperative fractures can occur in several ways. One of 
the most severe – but rare – fractures is that of the shaft of the femur, often necessitating 
extra extensive surgery. More frequent and less severe fractures are avulsions of the tip of 
the trochanter and non-unions of the trochanter osteotomy [23, 83]. Stress fractures of 
the pelvis are rare and can be treated conservatively [26]. 
Aseptic loosening
The mechanisms of aseptic loosening in cemented THA in RA have been related to the 
properties of the affected peri-articular bone and soft tissue in the hip joint. Three local 
processes of the disease can be identified: inflammation, increased bone turnover, and 
demineralization of bone. Inflammation of the joint involves subchondral bone and 
synovium producing cytokines such as interleukins and tumor necrosis factors [51]. 
Increased bone turnover, involves increased rates of bone formation and resorption [12, 
13]. The bone loss in patients with RA is a focal and generalized disorder affecting cortical 
and cancellous bone, characterized by a loss of bone volume and lower mineral content 
[2, 43, 56, 66, 67] and occasionally avascular necrosis of the head [106]. 
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Based on these three mechanisms in the affected hip joint several theories have been 
developed to describe the process of aseptic loosening of implants in RA. Inoue et al. [41] 
and Petra et al. [71] proposed that the inflammation in the peri-prosthetic tissue (or at 
the cement-bone interface) may cause the fixation to fail. Others proposed that loosening 
occurred due to increased turnover of bone and a greater amount of unmineralized tissue 
[2, 13, 67]. On the other hand Bogoch and Moran [13] suggested that increased bone 
formation rates may promote early bone ingrowth and enhance fixation of cementless 
implants in patients with RA. 
Nalepka et al. [63] suggested another mechanism of loosening. Based on bacterial 
endotoxins found in peri-prosthetic tissue in RA patients they suggest that failure is caused 
by subclinical infection. 
Mortality
An increased mortality risk has been reported in RA patients compared to patients without 
RA at 90 days after THA: odds ratio 1.88 (95% CI 1.17–3.03), p = 0.01 [85]. However, such 
an increased risk was not found in an earlier study [101]. In this study the peri-operative 
mortality within 30 days of THA in RA patients was 0.65% compared to OA of 0.73%. 
Perioperative management
Cervical spine instability
Cervical spine instability is common in RA patients. Excessive head movements or extreme 
passive head or neck position during anaesthesia may cause medullary compression 
with potential fatal consequences [61]. Radiographical cervical spine instability can 
be present without clinical symptoms. In a study by Collins et al. [22] radiographical 
cervical spine instability was present in more than 60% of RA patients undergoing knee 
or hip replacement. Only a small minority of these patients had any symptoms of cervical 
instability. It is advised to be cautious for cervical instability in all RA patients undergoing 
surgery with general anaesthesia.
Medication 
Anti-rheumatic drugs such as Disease Modifying Anti-rheumatic Drugs (DMARDs), 
immunesuppressive drugs and biologicals all have their influence on the immune system. 
There is no clear evidence that supports a direct relation between an increased risk of post-
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operative infections and anti-rheumatic medication, but case reports on opportunistic 
infections have been described. Considering this alleged increased risk for infections 
it could be beneficial to stop the medication peri-operatively. However, discontinuing 
anti-rheumatic drugs can induce an exacerbation of the inflammatory disease. At present 
there are no randomized clinical trials available that investigate the relation between 
medication-related postoperative complications and the risk on exacerbation of disease 
after joint replacement in RA. 
In the case of TNFα inhibitors discontinuing could be considered in individual cases 
with an increased risk for infection starting four times the half time. Depending on the 
specific drug this could be as long as 7 weeks – or even longer – before the day of surgery. 
In elective orthopaedic surgery the Dutch Society of Rheumatology advises to plan the 
operation halfway two gifts. In the event of a post-operative complication restarting has 
to be postponed until wound healing has occurred and infections are ruled out.
Technical surgical considerations 
Acetabular protrusion
Protrusion is a risk factor for early loosening of the cup and is observed in up to 40% of RA 
patients [68, 73]. Restoration of the centre of rotation is advocated to prevent migration 
and loosening of the cup and to prevent loss of offset that could cause instability of the 
hip. Bone grafting of the medial acetabular wall significantly improves the outcome of 
THA [8, 36, 44, 49, 68, 76–78].
Ipsilateral knee deformity
A stiff ipsilateral knee, or pathological laxity or a valgus- external rotation deformity of 
the knee, and failure to appreciate this at the time of surgery can cause problems with the 
orientation of the rotational plane of the femur. This can results in faulty estimation of 
femoral anteversion. 
Timing of surgery
Rehabilitation could be complicated due to upper limb limitations. Shoulder, elbow, wrist, 
and hand involvement can limit the use of crutches. It may be necessary to undertake 
surgical treatment of other joints before that of the hip to ensure a smooth rehabilitation. 
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Knee surgery is better left until after hip replacement since it is difficult to rehabilitate the 
knee if there is marked stiffness and pain in the hip [31, 61].
One stage bilateral total hip arthroplasty, or one stage hip and contra-lateral knee 
arthroplasty are options that could be considered but are associated with increased 
complication rates [1].
The pre-operative status of the joint determines post-operative function, thus postponing 
joint replacement could result in less functional outcome [61, 64]. Early operation on those 
patients showing rapid development of protrusio acetabuli may prevent complications as 
postponing of surgery could lead to progressive protrusion.
It is clear and important that timing of the operation is the key to success in RA surgery. 
Outcome of THA in RA
There is little discussion that THA in RA is a major advancement in the treatment of patients 
with pain and disability due to end-stage hip disease. However, outcome assessment of 
THA in a chronic multiple joint affecting disease as RA is even harder than in osteoarthritis 
patients [54]. Pain, range of motion, morbidity due to complications, mortality, radiological 
assessment, survival, functional capacity and quality of life, patient satisfaction and cost-
benefit analysis are all parameters used to assess outcome. Unfortunately different scales 
and measurement tools are used each with its own nomenclature and classification. 
The strongest effect of THA is the improvement of pain [9, 18, 26, 48, 50, 52, 87]. 
Improvement in function is related to involvement of knee, ankle and foot deformities 
that could limit the ability to walk [60]. Only 61% of patients improve on Merle D’Aubigne 
and Postel walking score after THA [42]. Even after good short term results after joint 
replacement in nonambulatory patients walking ability deteriorated over the years in half 
of the patients [105]. 
Although RA patients with multiple arthroplasties in the lower extremities improve 
their quality of life, they are still afflicted with secondary diseases derived from RA and 
experience complications that may shorten their lifespan [47, 55].
Multiple joint replacements are sometimes necessary to reduce pain, increase mobility, and 
improve independence. Although many patients improve after 3 or 4 TJA the cumulative 
long-term complication rates are impressive and reach up to 43% per implant when septic 
and aseptic complications are combined [46]. 
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Summary
Standard cemented THA has been for many years the treatment of choice in destructive hip 
disease in RA. Patients with RA are generally considered to be more prone to complications 
after hip replacement due to the nature of the disease with its deleterious effects on the bone 
and soft tissues, and due to the side effects of anti-rheumatic drug treatment. Perioperative 
management includes cautiousness for cervical spine instability, management of anti-
rheumatic medication, and preoperative surgical planning to prevent malpositioning of 
implants. Timing of the operation is the key to success in RA surgery.
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Abstract
Patients suffering from rheumatoid arthritis typically have a poor subchondral bone quality, 
endangering implant fixation. Using finite element analysis (FEA) an investigation was 
made to find whether a press-fit acetabular implant with a polar clearance would reduce 
interfacial micromotions and improve fixation compared with a standard hemispherical 
design. In addition, the effects of interference fit, friction, and implant material were 
analysed. 
Cups were introduced into an FEA model of a human pelvis with simulated subchondral 
bone plasticity. The models were loaded with a loading configuration simulating two 
cycles of normal walking, during which contact stresses and interfacial micromotions 
were monitored.Subsequently, a lever-out simulation was performed to assess the fixation 
strength of the various cases.
A flattened cup with good bone quality produced the lowest interfacial micromotions. Poor 
bone decreased the fixation strength regardless of the geometry of the cup. Increasing the 
interference fit of the flattened cup compensated for the loss of fixation strength caused 
by poor bone quality.
In conclusion, a flattened cup did not significantly improve implant fixation over a 
hemispherical cup in the case of poor bone quality. However, implant fixation can be 
optimized by increasing interference fit and avoiding inferior frictional properties and 
low-stiffness implants. 
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Introduction
Reports on patient demographics have shown that approximately 11 percent of all patients 
suffering from rheumatoid arthritis (RA) will undergo total hip joint arthroplasty at some 
point [20]. Due to the reduced bone quality of RA patients, some surgeons prefer to use 
a cemented acetabular implant in such cases [15], although cementless press-fit implants 
are also being used.
The initial fixation of press-fit cups is achieved by compressive and frictional forces of the 
acetabulur cavity acting on the cup surface, which counterbalance the hip joint contact 
force [16]. This fixation mainly takes place by clamping of the cup in the peripheral rim of 
the acetabulum [1, 8, 10, 11, 22]. A good initial fixation, limiting interfacial micromotions, 
is mandatory to achieve bony ingrowth and proper long-term fixation [13, 17].
Implantation and positioning plays an important role in the fixation of standard, 
hemispherical press-fit acetabular implants. There is a risk of seating of the pole of the 
implant against the bottom of the acetabulum before rim fixation can take place, which 
could lead to inadequate initial fixation [21, 14]. On the other hand, when rim fixation 
does occur before the pole has reached the bottom, a gap at the pole will remain. In this 
situation, the contact area between the bone and implant will be limited to a line at the 
peripheral rim, jeopardizing the initial fixation and ingrowth of bone [1, 9, 11, 12]. In 
addition, poor bone quality may further affect the clamping of a press-fit implant by the 
acetabulum.
To account for these potential drawbacks hemispherical cup design a flattened design 
was developed. The objective of this design is to achieve fixation at the peripheral rim 
by flattening of the pole, leaving a predefined polar clearance between the implant and 
acetabulum. Sufficient contact between the bone and implant is achieved by a triple 
radius profile that ensures a broad band of contact at the peripheral part of the wall of the 
acetabulum (Figure 3.1). Thus, a cup with a polar clearance may improve implant fixation, 
making it suitable also for patients with poor acetabular bone quality.
Additional fixation of an implant with a polar clearance may be achieved by increasing 
the relative sizing of the cup compared with the reamed acetabulum, leading to a larger 
interference fit. On the other hand, implant fixation may be jeopardized by reduced friction 
at the implant–bone interface, since it is likely that poor bone quality effectively reduces 
the frictional properties. Finally, designs have been introduced to the orthopaedic market 
that are made of osteoconductive materials, such as tantalum, to promote bony ingrowth. 
However, since such materials typically have a lower stiffness, the initial fixation may be 
adversely affected.
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It is currently not known what implications these surgical and design-related variations 
may have on the fixation of press-fit acetabular implants. Therefore, using finite element 
analysis (FEA), an attempt was made to answer the following questions: (1) Does a flattened 
cup improve implant fixation in the case of poor bone quality? and (2) How do variations 
of interference fit, frictional properties, and implant stiffness affect the initial fixation of 
a flattened pressfit acetabular cup?
Methods
A flattened cup design with a polar clearance (based on the EP-FIT cup, Smith & Nephew 
Orthopaedics AG, Rotkreuz, Switzerland; Figure 3.1) and a hemispherical cup were 
analysed using FEA. Both cup designs had an outside diameter of 53 mm and consisted 
of a metal shell and a polyethylene liner. The minimal thickness of the metal shell was 3.5 
mm and the average thickness of the liner was 9 mm in both implant designs. The cups 
were introduced into an FEA model of a human pelvis [4] (Figure 3.2). The cups were 
placed such that the femoral head centre was reconstructed, and at an inclination angle 
of 45° and 15° of anteversion (Figure 3.3).
The pelvic model consisted of eight-node brick elements with trilinear interpolation 
functions to simulate the trabecular and subchondral bone and membrane elements to 
Figure 3.1 Transverse section of the outer geometry of the modular titanium EP-FIT. The shell 
is characterized by a triple radius outer profile, with a peripheral part of the acetabulum (R1), a 
transition zone (R2), and a gap between the cup and the bone in the polar zone of 1 to 2 mm (R3).
31
Chapter 3Finite element analysis of cementless cup fixation
Figure 3.2 The finite element model of the human pelvis used for the analysis with implanted 
acetabular cup.
Figure 3.3 Positioning of the implant in the acetabulum, showing the cup inclination (left) 
and anteversion (right) angles.
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simulate the cortical bone. All implant materials were assumed to be isotropic and linear 
elastic. The material properties and thickness of the cortical elements were previously 
assessed by quantitative computer tomography [4]. Young’s modulus of the trabecular and 
subchondral bone ranged from 1 to 2155 MPa, while the thickness of the cortical layer ranged 
from 0.7 to 3.2 mm, with an average of 1.5 mm (Table 3.1). In cases with poor subchondral 
bone quality, the local Young’s modulus of the bone was reduced by 50 percent. The two 
pelvic bones forming the pelvis were joined at the pubic symphysis by rigid links, tying all 
degrees of freedom. The original model was refined for the current study, to enable a study 
to be made of the implant–bone interface mechanics in greater detail, resulting in a model 
consisting of 16288 elements and 15584 nodal points, against 2602 elements and 1862 
nodal points for the original model. The refined model compared favourably against data 
from experiments with the fresh human pelvis that served as the basis for the model [4].
In order to prevent high stresses exceeding the yield strength of the subchondral bone 
upon insertion and loading of the oversized cups, plastic material behaviour was simulated 
based on data of Kaneko et al. [7]. These data provide relationships between the bone ash 
density, Young’s modulus, and the yield stress. Based upon the local Young’s modulus of 
the pelvic model, the yield stress was calculated for each element of the subchondral bone. 
The bone material was assumed to be linear elastic–plastic. After reaching the yield point, 
the effective stiffness of the material was assumed to be equal to 50 percent of the initial 
Young’s modulus. In the models in which poor periprosthetic bone quality was assumed, 
the plastic material properties were adjusted accordingly.
Contact between the acetabular implant and the subchondral bone was modelled using a 
doublesided node-to-surface contact algorithm (MSC.Marc, Santa Ana, California, USA). 
The implant–bone interface was assumed to be debonded, while friction was modelled 
using a Coulomb stick–slip model. A default friction coefficient of 0.5 applied, which is 
in the range of friction coefficients for cementless implants [5, 19].
Table 3.1 Material properties used in the finite element models
Young’s modulus [MPa] Poisson’s ratio [-]
Pelvis Cortical bone 17000 0.3
Trabecular bone 1 to 132 0.2
Subchondral bone 186 to 2155 0.2
Implant Shell (titanium or tantalum) 110000 or 3000 0.3
Polyethylene liner 700 0.45
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The press-fit fixation of the cups was achieved using the contact algorithm. At the start 
of each simulation, the oversized cup was placed in the acetabulum, with its elements 
penetrating the subchondral bone elements. Subsequently, during a preconditioning phase 
of three increments, the nodes at the surface of the subchondral bone were ‘pulled’ towards 
the cup surface by the contact algorithm. The default amount of interference fit was 1.0 
mm, meaning that initially the diameter of the implant was 1.0 mm larger than the outside 
diameter of the acetabulum. The hemispherical cup was assumed to be in contact with 
all subchondral bone, initially. Approximately 50 percent of the outer surface of the cups 
with a polar clearance was initially in contact with the subchondral bone. The maximal 
amount of polar clearance was 2.5 mm for this cup.
The models were subjected to loads representing a cycle of normal walking [3]. The walking 
cycle was divided in eight different phases, during which 21 muscle forces were applied 
(Table 3.2, Figure 3.4). The hip joint contact force was applied to a spherical rigid body 
representing the prosthetic femoral head. Frictionless contact was simulated between the 
prosthetic head and the polyethylene liner. The hip joint contact force and muscle loads 
were based on a body weight of 650 N [3]. The pelvic model was fixed in all directions at 
the sacro-iliac joint areas of both pelvic bones. All models were subjected to two cycles 
of normal walking. The results presented in this study were collected during the second 
walking cycle, to allow for settling of the acetabular implant during the first walking cycle.
In total, eight different models were analysed (Table 3.3). Two models with a hemispherical 
cup and a polar clearance cup implanted in a pelvis with good bone quality served as the 
base references. The results of these simulations were compared with those of two models 
Table 3.2 Description of the phases of the walking cycle that were simulated and the flexion/
extension angles between the pelvis and the femur 
Phase Description Walking cycle (%) Flexion angle (deg)
1 Double support, beginning left stance phase 2 22 (flexion)
2 Beginning left single support phase 13 18 (flexion)
3 Halfway left single support phase 35 4 (extension)
4 End left single support phase 48 12 (extension)
5 Double support, end left stance phase 52 14 (extension)
6 Beginning left swing phase 63 2 (flexion)
7 Halfway left swing phase 85 31 (flexion)
8 End left swing phase 98 21 (flexion)
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Figure 3.4 Simulated muscle loads acting on the pelvis during a specific phase 2 of the walking 
cycle (beginning of the left single support phase; maximal load).
Table 3.3 Overview of the simulations performed. The grey areas indicate the variations
1 2 3 4 5 6 7 8
Implant 
design
Polar
clearance
Hemi Polar
clearance
Hemi Polar
clearance
Polar
clearance
Polar
clearance
Polar
clearance
Bone quality Good Good Poor Poor Poor Poor Poor Poor
Interference 
fit (mm)
1.0 1.0 1.0 1.0 0.0 2.0 1.0 1.0
Friction 
coefficient 
0.5 0.5 0.5 0.5 0.5 0.5 0.2 0.5
Implant 
material
Ti Ti Ti Ti Ti Ti Ti Ta
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with a hemispherical and polar clearance cup implanted in poor subchondral bone quality. 
In four additional models the effect of parametric variations was analysed. The level of 
interference fit (0.0 and 2.0 mm versus the default of 1.0 mm) was varied. Furthermore, a 
model with a low friction coefficient (0.2 versus the default value of 0.5) was simulated as 
a representation for an interface with inferior interface characteristics (poor bone quality, 
presence of fat and blood at the interface). Finally, the effect of a low stiffness cup (3.0 
GPa versus the default of 100 GPa) was analysed, simulating a cup made from trabecular 
metal. In total, eight different cases were analysed.
During the walking cycle, the contact normal stress and micromotions at the implant–bone 
interface were calculated as a measure for implant fixation. Micromotions were calculated 
by tracking the relative sliding of all contact points at the implant and bone surface (MSC.
Marc, Santa Ana, California, USA). To quantify the actual fixation strength further, a leverout 
simulation was performed after the simulation of normal walking. During this simulation, 
a force was applied to a lever attached to the metal shell of the implant, at a distance of 0.10 
m from the cup centre. The force was increased with 5.0 N increments (0.5 Nm torque load 
increments) until the implant fixation failed. Since the lever-out simulation was force-driven, 
the point of failure of fixation was indicated by calculations failing to converge.
Results
Fixation of a cup with a polar clearance versus hemispherical cup
There were distinct differences between the two implant designs considering the load 
transfer from the subchondral bone to the implant. In the models with a polar clearance 
cup contact stresses were mainly concentrated in the peripheral region, while in models 
with a hemispherical cup some load transfer also took place in the dome of the acetabulum 
(Figure 3.5). During the second phase of the walking cycle (beginning of the single support), 
during which the largest external forces were applied, the maximal contact normal stress 
was higher in the model with the polar clearance cup than with the hemispherical cup 
(Table 3.4).
Differences were also found between the distributions of micromotion at the implant–
bone interface. In the case of good bone quality, the model with the polar clearance cup 
predicted small areas of micromotion in the peripheral region, while in the model with 
a hemispherical cup these areas extended to the dome of the acetabulum (Figure 3.6). 
During the beginning of the single support phase, the maximal micromotion was slightly 
higher in the hemispherical cup model (Table 3.4).
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Poor bone quality led to a significant reduction in the contact normal stresses for both 
implant designs (Table 3.4), although their distribution remained similar to that in the 
case of good bone quality (Figure 3.6). Furthermore, poor bone quality resulted in larger 
micromotions at the implant–bone interface. In the model with the polar clearance cup, the 
implant migrated, even resulting in contact in the dome region of the acetabulum during 
the second phase of the walking cycle (Figure 3.6). In the model with the hemispherical 
cup, the micromotions also increased, although their distribution was similar to that of a 
cup implanted in bone with a good quality.
Figure 3.5 Contact stress distribution during the second phase of the walking cycle, in case 
of good bone quality. On the left (A), the subchondral bone surrounding a cup with a polar 
clearance is shown (Case 1); on the right (B) the bone surrounding a hemispherical cup (Case 2).
(B)(A)
Table 3.4 Overview of results from the FEA simulations. The maximal contact stress and 
maximal micromotion are shown for the second phase of the walking cycle (beginning of single 
support), since in this phase the largest external loads were applied to the models. 
Bone quality Maximum contact 
stress (MPa)
Maximum micro-
motion (μm)
Lever-out 
moment (Nm)
Good Clearance cup 25.2 174 5.5
Hemispherical cup 20.7 179 6.5
Poor Clearance cup 10.4 455 4.0
Hemispherical cup 17.6 381 6.0
Clearance cup, low interference 12.6 878 3.0
Clearance cup, high interference 17.5 702 13.5
Clearance cup, low friction 16.1 1620 5.5
Clearance cup, low stiffness 9.9 481 1.5
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Applying a lever-out load after the simulation of two cycles of normal walking indicated 
that the hemispherical cup had a stronger fixation than the polar clearance cup, both in 
the case of good and poor bone quality (Table 3.4).
Eﬀ ect of parametric variations on the ﬁ xation of the polar clearance cup
Reducing the interference fit of the polar clearance cup led to a slight increase in the 
maximal contact normal stress, although the micromotions at the implant–bone interface 
were almost two times higher than in the case of the default interface fit. In addition, the 
low-interference cup led to a lower lever-out moment.
Increasing the interference fit resulted in a higher contact normal stress at the implant–
bone interface, although relatively high micromotions were still found in this model. 
However, as anticipated, the larger interference did lead to a significant increase in the 
lever-out moment.
Simulating inferior frictional properties at the interface had a negligible effect on the 
maximal contact normal stress, although the interfacial micromotions were almost four 
times higher than with the default friction coefficient. Surprisingly, the model with reduced 
friction did result in a slight increase of the lever-out moment.
Finally, a low-stiffness cup caused a reduction in the maximal contact normal stress and a 
slight increase in the interfacial micromotions. The leverout moment, however, was much 
lower compared with the default stiffness cup.
Discussion
Coming back to the first research question, the results of the current study suggest that 
a flattened design does not improve implant fixation in the case of poor bone quality. A 
polar clearance cup did not lead to lower interfacial micromotions or to a higher fixation 
strength compared with a hemispherical design. However, different ways of fixation were 
found for the two implant designs. While the hemispherical cup displayed a larger area 
of contact, the cup with a polar clearance had higher contact stresses, which were mainly 
concentrated at the peripheral rim. In the case of good bone quality, this led to differences 
in the interfacial micromotion patterns, although no significant differences in maximal 
interfacial micromotions were found.
These findings are in line with other studies on flattened cups. A study with a three-
dimensional photo-elastic model [14] showed that loading a hemispherical cup increases 
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load transfer in the dome and decreases load transfer at the rim, suggesting that there 
may be less press-fit stability of the cup with increasing load. With a nonhemispherical 
cup, peripheral stresses remained higher under increasing load than dome stresses, 
suggesting that initial stability is better with a nonhemispherical geometry. In a cadaver 
study [22], stress distributions were compared between natural hip joints and a flattened 
and a hemispherical cup. The natural hip joint showed high stresses in the rim of the 
acetabulum, mainly in the ischial, iliac, and pubic facets, and low stresses in the fovea. 
This distribution was similar with the flattened cup, while the hemispherical cup showed 
non-physiological pole contact. 
To answer the second research question, the effect was studied of variations of interference 
fit, frictional properties, and implant stiffness on the initial fixation of a flattened press-fit 
acetabular cup.
The simulations indicate that the fixation of pressfit cups with a polar clearance can be 
improved by increasing the interference fit of the implant. The model with the large 
interference fit displayed the highest resistance against a lever-out load, which is in line 
with other studies that showed that interference fit is one of the most important factors 
in achieving adequate fixation [2, 10, 18]. Extrapolated to the clinical situation, this 
suggests that loss of initial fixation caused by poor bone quality, as in RA patients, can 
be compensated when an extra interference fit is used. Despite its high fixation strength, 
an increased interference fit still led to relatively high maximal interfacial micromotions. 
These occurred at regions where the fixation was less optimal, and were most likely caused 
by stiffness variations of the subchondral and cortical bone at the peripheral rim of the 
acetabulum.
A low interference fit resulted in a very low fixation strength, and caused excessive 
interfacial micromotions, to such an extent that long-term fixation through bone in- and 
ongrowth may be jeopardized [6]. This suggests that in the case of poor subchondral bone 
quality and a standard size acetabular implant, additional fixation measures, such as the 
use of bone screws, are required to ensure proper initial and long-term fixation.
The simulations showed that inferior frictional properties at the implant–bone interface 
will jeopardize stability. The low-friction case displayed the highest micromotions (1620 
μm) at the implant–bone interface. Surprisingly, the lever-out simulations showed that the 
fixation of a low-friction cup was rather high, while an inferior fixation strength would be 
expected in such a case. Possibly, the implant was jammed within the acetabulum due to 
extensive migration of the cup during the walking loading history, which has previously 
been demonstrated by Spears et al. [18] with similar frictional properties.
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In theory, a flexible cup should mimic a more physiological loading situation and thus 
a more natural load transfer and stress distribution [12]. However, the present findings 
indicate that a lowstiffness implant endangers the fixation strength. This may be due to 
the fact that the implant stiffness was in the range of, or at some locations even lower than, 
the stiffness of the subchondral bone. It therefore seems that the drawbacks of such an 
implant may outweigh its possible benefits.
Evidently, the current FEA models had some limitations with regards to positioning of 
the implants, bone material properties, and interfacial parameters.
An optimal implantation was assumed for both implant types, while in clinical practice 
the implant position may be jeopardized by an irregular shape of the acetabulum or by 
malpositioning of the implant, especially in the case of poor bone quality. Compared with 
such cases, the results of the current study may overestimate the actual quality of fixation. 
Poor bone quality resulting from RA was represented in the FEA models by a 50 percent 
reduction of the local bone stiffness. Although these results indicate that this has a 
significant effect on the results, it is not possible actually to verify the accuracy of the 
input data, due to a lack of data on the mechanical properties of rheumatoid bone. In 
addition, to the authors’ knowledge no data have been reported on experiments with 
press-fit acetabular cups implanted in rheumatoid subchondral bone that could further 
validate the modelling approach.
In order to provide a more realistic representation of the actual bone material behaviour, 
plasticity was introduced to the subchondral bone. The local bone yield point was based 
on data by Kaneko et al. [7], who tested trabecular bone specimens from distal femora. 
Post-yield mechanical behaviour was simulated by assuming a reduction by a factor 2 of the 
local stiffness. Unfortunately, no data are currently available to validate whether the plastic 
behaviour simulated in these models is in the range of the actual plastic deformations 
occurring in the subchondral bone. However, it was found that adding bone plasticity 
has a considerable effect on the interfacial mechanics. In an initial study with only elastic 
material properties assigned to the bone stresses were found that far exceeded the yield 
stress. These large interface stresses improved fixation and caused a reduction in the 
interfacial micromotions. The effect of bone material properties may partially explain 
the differences between interfacial micromotions reported earlier by Spears et al. [19], 
who used elastic material properties and found a maximal micromotion value of 100 μm 
during normal walking, compared to 179 μm in the current study (hemispherical cup, 
good bone quality). 
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The default friction coefficient that was used in the models was similar to that used by 
Spears et al. [19]. The friction coefficient value of 0.2 was chosen somewhat arbitrarily as 
a representation for an interface with inferior characteristics (bone affected by RA and the 
presence of fat and blood at the interface), since no data are available from the literature on 
the frictional properties under such conditions. In addition, the models were too coarse 
to capture the effect of surface irregularities such as anchoring rims, which may provide 
additional stability. Modelling the anchoring rims would have required a typical element 
size of about 0.1 mm, leading to too high computational costs. 
In conclusion, it was found that (1) a flattened cup did not significantly improve implant 
fixation over a hemispherical cup in the case of poor bone quality. However, the initial 
fixation of a press-fit cup with a polar clearance can be optimized by (2) increasing the 
interference fit, by avoiding inferior frictional properties at the implant–bone interface, 
and by avoiding low-stiffness material properties for the design. 
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Long-term results of cementless primary 
total hip arthroplasty with a threaded cup 
and a tapered, rectangular titanium stem 
in rheumatoid arthritis and osteoarthritis
Rob E Zwartelé, Anil Peters, Johannes Brouwers, 
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Abstract
The aim of this study was to assess the outcome of primary cementless total hip arthroplasty 
in rheumatoid arthritis patients and to compare the results with osteoarthritis patients. 
Sixty-four patients (77 hips) with rheumatoid arthritis and 120 patients (135 hips) with 
osteoarthritis had a conically-shaped Zweymueller threaded cup and a tapered, rectan-
gular Zweymueller stem implanted and were assessed after an average of 12.5 years. The 
endpoints for survival analysis were failure of one or both components due to radiographic 
loosening or revision. Revision was defined as exchange of cup, stem or both. When the 
PE-insert or the ceramic ball head were exchanged leaving cup and stem in place, e.g. 
for PE-wear or dislocation, this was not considered a revision but a re-intervention. No 
differences were found in survival rates; however, in the rheumatoid arthritis group there 
was an increased rate of malposition of the cup, avulsions of the greater trochanter, and 
increased bone resorption in the trochanteric region. This study shows that despite altered 
biomechanical properties of rheumatoid bone, mechanical stability and osseous integra-
tion of cementless prosthesis are not compromised and, although a higher complication 
rate did occur, long-term survival is excellent.  
47
Chapter 4Clinical study on cementless THA in RA
Introduction
The supposed increased long term survival of cementless total hip arthroplasty (THA) could 
be especially beneficial to the relatively young rheumatoid arthritis (RA) patient population. 
However, RA is associated with altered biological and mechanical bone properties [1, 3, 
4, 20, 21, 23]. This raises several potential complications when cementless prostheses are 
being used in RA patients. First of all, fractures of either the acetabulum or the femur could 
occur, both at the time of surgery and in the postoperative phase. Second, there could be 
an elevated risk of early aseptic loosening as a result of either a reduced primary stability 
of the implant, or of an altered metabolism of the bone, both potentially compromising 
the process of osseointegration.
Third, bone loss produced by stress-shielding around cementless stems may contribute 
to increased pain, periprosthetic fractures and eventually to loss of fixation [15]. This 
process of bone resorption is known to be more prominent when preoperative osteopenia 
is present as in RA patients [18, 19, 22].
To assess these potential complications a study was performed to analyse clinical and 
radiographic results of a group of RA patients after primary cementless THA and to 
compare these to the results of a group of OA patients.
Patients and methods
Between 1986 and 1992, 259 consecutive primary cementless THAs were carried out on 
223 patients. Sixty-four patients (77 hips) were classified as having RA, and 120 patients 
(135 hips) were classified as having OA. Patients with other diagnoses were not included.
The implant
The Zweymueller cup is a conically shaped threaded cup made of grit blasted titanium 
(Zimmer, formerly Sulzermedica, Wintherthur, Switzerland). The insert is made of ultra-
high molecular weight polyethylene. A 32 mm Biolox alumina ceramic ball head (Ceramtec, 
Plochingen, Germany) was used initially, and changed for a 28 mm Biolox alumina ceramic 
ball head (Ceramtec, Plochingen, Germany) from1990 onwards. The Zweymuller stem is a 
tapered, rectangular shaped grit-blasted titanium alloy stem. A first generation cementless 
Zweymueller (Hochgezogen) stem was used from 1986 to 1987 followed by the second 
generation SL-Zweymueller (step-less) stem (Sulzermedica, Wintherthur, Switzerland) 
from 1988 onwards.
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Surgical technique
Operations were performed with the patients lying supine using either an anterolateral or 
a straight lateral approach. 
Follow-up evaluation
All patients were seen 3 and 6 months postoperatively and thereafter annually or biannually. 
Clinical results were assessed using the Harris Hip Score (HHS) [14]. Patients were asked 
to classify their pain level into one of three categories: no pain, mild to moderate pain, 
marked pain.
Radiographic analysis
Standard radiographs in two directions of the hip were obtained pre- and post-operatively. 
Assessment of radiolucencies at the acetabular side was performed according to DeLee and 
Charnley [7] and on the femoral side according to Gruen et al. [13]. Wear of the insert, bone 
resorption, cortical hypertrophy, and osteolytic lesions were assessed according to criteria 
described by Johnston et al. [16]. Inclination of the cup was determined by measuring the 
angle between the inter-teardrop line and a line through the opening plane of the cup. 
Malposition of the cup was defined as either perforation through the acetabular floor, a 
position more than 1 cm too cranial to the anatomical acetabulum, or an inclination of 
more than 55 degrees or less than 40 degrees. Malposition of the stem was defined as more 
than 2 degrees of varus or valgus alignment or a position more than 1 cm too cranial to 
the tip of the greater trochanter. Change in component position (migration, tilting, and 
subsidence) was determined by comparison between consecutive radiographs. Implant 
stability was defined according to the criteria described by Engh et al. [11].
Statistical analysis
The two diagnostic groups were compared either by using Fisher’s exact test or the chi-
square test for 2×2 tables whenever the outcome was a dichotomous variable; the student 
t-test in case of continuous outcome variables; or a survival approach using Kaplan-Meier 
estimates and Cox proportional hazards models in the case of a dichotomous outcome 
as a function of “time since operation”. In all cases p-values of < 0.05 were considered 
statistically significant.
The probability of implant survival was estimated by Kaplan-Meier survival analysis in both 
diagnostic groups for the THA as a whole and for stem and cup separately. The survival 
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analyses were each done twice; once for failure of the implant due to any cause, and once 
for failure due to aseptic loosening in which case a failure due to any other cause than 
aseptic loosening was treated as a censoring event in the Kaplan-Meier or Cox model.
Since aseptic loosening and non-aseptic loosening are actually “competing risks” and 
together define the event “overall failure”, the Kaplan-Meier estimates are themselves 
incorrect for the purpose of estimating the true probabilities in the population. Although 
the relative risks comparing the two diagnostic groups are estimated correctly for aseptic 
loosening and non-aseptic loosening respectively, the survival curves themselves should 
be calculated by a competing risk method, for which the package NCSS 2000 was used. In 
such a competing risk context, the sum of the survival curves for aseptic and non-aseptic 
loosening add up exactly to the overall survival curve (“due to any cause”). The relation 
between the diagnostic group and the risk of failure is estimated in the Cox framework. 
The test used to compare diagnostic groups is the log-rank test.
The endpoints for the survival analysis were failure due to radiographic loosening, revision 
of a component for any reason and revision of a component for aseptic loosening. Revision 
was defined as exchange of cup, stem or both components. When the PE-insert was 
exchanged for wear – leaving cup and stem in pace – this was considered as failure of the 
insert and not as failure of the cup. Also, when the ball-head was exchanged for recurrent 
dislocation, this was not considered as failure of the prosthesis. Therefore these procedures 
were not considered as revisions but as a re-interventions. 
All data were stored in a database developed for data management of prosthetic surgery 
(Project Manager, version 7.0; Department of Medical Statistics, LUMC, Leiden, the 
Netherlands). This program was linked to SPSS version 10.1 (SPSS, Chicago, Illinois) for 
statistical analysis and to NCSS 2000 for the analysis of competing risks.
Results
The RA group was significantly younger than the OA group. The average age at operation 
in the RA group was 59.1 years (SD 11.5, range 27.1–78.4 years), and for the OA group the 
average was 65.9 years (SD 7.4, range 40.9–82.5 years). Gender distribution was the same 
in both groups (RA group: 22 male out of 77; OA group: 26 male out of 135). Sixty-three 
cases (29 RA, 34 OA) died before 10 years of follow-up was obtained. Two patients lived 
abroad (2 hips: 1 RA, 1 OA) and were eventually lost to follow-up at 51 and 95 months 
postoperative, respectively. Up to that time these patients had no complaints of hip pain. 
The mean follow-up time was 150 months (range 120–210 months).
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The HHS improved significantly after surgery in both groups and this gain was maintained 
over the years; preoperative HHS, RA group: 28.7 (SD 15.6; range 15–74), OA group: 40.5 
(SD 13.8, range 18–74).
Intraoperative complications
Acetabulum
Perforation of the cup through the acetabular floor (Figure 4.1a) and malposition of the 
cup more than 1 cm too cranial to the anatomical acetabulum (Figure 4.1b) occurred 
more frequently in the RA group than in the OA group; 4 out of 77 versus 1 out of 135 
(p < 0.05), and 5 out of 77 versus 0 out of 135 (p < 0.05), respectively. None of these cups 
developed aseptic loosening.
The incidence of malposition of more than 55 degrees or less than 40 degrees inclination 
was not different between the groups.
Figure 4.1 (A) Protrusion of the cup through the acetabular floor perforating the internal lamina 
of the pelvis. (B) A too cranial position of the cup in relation to the anatomical acetabulum. (C) 
Tilting of the cup with radiolucent lines in all three zones 2 1/2 years after implantation.
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Femur
Avulsion of the tip of the greater trochanter occurred significantly more in the RA group 
than in the OA group; 10 out of 77 versus 4 out of 125 (p < 0.05). No relation was found 
to the survival of the implant or to other complications. 
Incomplete shaft fractures were seen once in the RA group and twice in the OA group. 
These fractures were all secured by tension band wires and healed without complications.
Revisions
Acetabular component
In the RA group six cups needed revision, four due to aseptic loosening. Two of these 
occurred in an early phase, one of which was revised 31 months after the operation (Figure 
4.1c), while the other patient was also scheduled for revision but died due to co-morbidity 
from cardiovascular disease before the operation was carried out and is not mentioned in 
Table 4.1. For the survival analysis this case was classified as aseptic loosening. The two 
other cups developed signs of aseptic loosening in a later phase. They were combined 
with polyethylene (PE) wear and the development of osteolytic lesions and were revised 
after 117 and 123 months, respectively. Traumatic fracture of the acetabulum with tilting 
of the cup required revision in two RA patients, 102 and 112 months postoperatively. In 
the RA group, no cups were revised for infection or recurrent dislocations and none of 
the revised cups were in malposition.
In the OA group eight cups were revised, three due to aseptic loosening; one cup with 
early loosening was revised after 40 months, two cups were revised in a later phase after, 
respectively, 76 and 123 months for aseptic loosening in combination with PE wear and 
the development of osteolytic lesions. None of these cups were malpositioned. Two other 
cups were revised for malposition; protrusio position of the cup induced instability due 
to lack of sufficient off-set in one hip. In another hip the anterior acetabular wall was 
damaged during reaming leaving the cup unstable. Two revisions were performed due to 
infection, and one for recurrent dislocation. 
Femoral component
In the RA group one stem was revised together with the cup 123 months after the index 
operation due to severe PE wear in combination with extensive osteolytic lesions in the 
proximal femur and acetabulum.
In the OA group five stems were revised, four of which were for extensive osteolytic lesions 
in the proximal femur in combination with severe PE wear. One stem was revised due 
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to malposition; the stem was placed too high and the patient complained of leg length 
discrepancy and thigh pain.
In all stem revisions the component was well anchored, necessitating a longitudinal 
osteotomy at the lateral side of the proximal femur in order to remove the stem.
Re-interventions
No re-interventions had to be carried out in the RA group. In the OA group nine re-
interventions were carried out. In four hips recurrent dislocations developed. All four 
were treated successfully by implanting a longer ceramic ball head. In three hips the insert 
was exchanged because of PE wear. In two hips removal of heterotopic ossifications was 
carried out for complaints of pain and stiffness.
Radiographic results
Acetabulum
Incidence and distribution of radiolucent lines were not significantly different between the 
two groups. Bone atrophy was seen more often in the RA group than in the OA group; 8 
out of 43 versus 2 out of 92 (p < 0.01) (Figure 4.2). Osteolytic lesions were not found. All 
cups in both groups were classified as stable.
Figure 4.2 AP radiograph of the left hip of a 78-year-
old female patient with rheumatoid arthritis 11 years 
after implantation of the Zweymueller prosthesis. Typical 
radiographic result with bone atrophy in the acetabulum 
in zones I and II, thin radiolucent lines around the stem in 
zones I and VII, and bone atrophy in the proximal femur in 
zones I and VII.
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Femur
Incidence of radiolucent lines around the proximal part of the stem in the RA group was 
slightly lower than in the OA group; 12 out of 47 versus 40 out of 95 (p = 0.05). Bone 
atrophy was found in the majority of the femora in both groups, predominantly in zones 
I and VII (Figure 4.2). In the RA group there were significantly more femora with bone 
atrophy in three or more zones; 18 out of 47 versus 13 out of 95 (p < 0.01). Osteolytic 
lesions were seen around two stems in each group.
Figure 4.3 Kaplan-Meier survival analysis of the cup (A) and stem (B) with failure due to aseptic 
loosening as endpoint. Failure due to any cause other than aseptic loosening was regarded as 
a censoring event. X-axis: months since operation. Y-axis: proportion of components unrevised. 
For confidence intervals at ten years see text.
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Figure 4.4 Cumulative incidence of failure of one or both components of THA in a competing 
risk setting, by diagnostic group (left panel RA group; right panel OA group). X-axis: time in 
months since operation. Yaxis: probability of failure. Light grey area: probability of failure due 
to aseptic loosening (both early loosening and late loosening with osteolytic lesions and PE 
wear). Dark grey area: probability of failure due to other causes such as peri-prosthetic fracture, 
infection, malposition and recurrent dislocation.
Survival analysis
The failure rate for the acetabular component due to aseptic loosening after an average 
follow-up of 125 months (range 6–210) was 5.2% in the RA group and 2.2% in the OA group. 
The ten-year survival of the cup in the RA group with failure due to aseptic loosening as the 
endpoint was 0.95 [95% CI 0.90–1.0] while in the OA group it was 0.98 [95% confidence 
interval (CI) 0.96–1.00] (Figure 4.3a).
The failure rate due to aseptic loosening for the stem after an average follow-up of 125 
months (6–210) was 1.3% in the RA group and 3.7% in the OA group. The ten year survival 
of the stem in the RA group with failure due to aseptic loosening as the endpoint was 1.0 
while in the OA group it was 0.97 [95% CI 0.97–0.99] (Figure 4.3b).
None of the survival analyses showed significant differences between the two groups.
The cumulative probability of failure of one or both components split for aseptic loosening 
and other causes of component failure such as peri-prosthetic fracture, infection, 
malposition and recurrent dislocation are presented in Figure 4.4.
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Discussion
Several studies show increased loosening of cemented THA in patients with RA [5, 17], 
but publications on cementless Zweymueller THA in RA patients are scarce. Publications 
on this prosthesis in OA patients report good results [6, 10, 12, 24, 25].
We found two studies on the Zweymueller cup in RA patients. Dominkus et al. [8] found 
4% loosening rate in 82 THAs in 61 RA patients after 7 years (range 2–10) while Arnold 
et al. [2] report on a multi-centre study with several cementless designs after 6.9 years 
including 591 patients diagnosed with inflammatory joint disease. They concluded that 
all cementless prostheses could be used safely in RA patients.
On the Zweymueller stem in RA patients we found only one study. Effenberger et al. [9] 
reported only one stem revision for a traumatic femoral fracture in 60 THAs after 49 
months (range 12–131).
In our material several complications occurred more frequently in the RA group: 
perforation of the cup through the acetabular floor and malposition of the cup in a too 
cranial position. Together with the two traumatic fractures of the acetabulum with tilting 
of the cup in the RA group and the increased rate of avulsions of the tip of the greater 
trochanter, these findings suggest a tendency for a higher rate of fractures in RA patients 
caused by the altered mechanical properties of the rheumatoid bone. Also, an increased 
rate of bone atrophy in the acetabulum and the proximal femur was found in the RA group 
compared to the OA group.
Thus far, this increased bone atrophy in the RA group did not lead to an increase in clinically 
related consequences, such as pain, aseptic loosening, and peri-prosthetic fractures in 
comparison with the OA group.
In summary, this study shows that the mechanical stability and the process of osseous 
integration on the cementless Zweymueller hip prosthesis does not seem to be compromised 
in RA patients as early aseptic loosening and long term survival were similar in the two 
diagnostic groups. However, the increased complication rates in RA patients (malposition 
of the cup, avulsions of the tip of the greater trochanter, and bone atrophy) confirm the 
concerns based on the altered biomechanical properties of the softer rheumatoid bone 
with this type of implant. In contrast to the very satisfactory results with the femoral 
component, accurate positioning of the threaded acetabular component appears to be a 
problem in RA patients.
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Primary total hip arthroplasty with a 
flattened press-fit acetabular component 
in osteoarthritis and inflammatory 
arthritis: A prospective study on 416 hips 
with 6–10 years follow-up
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Abstract
Introduction: A flattened cup was designed to create a more physiological load transfer to 
the pelvic bone compared to hemispherical cups, and to allow more bone contact compared 
to low-profile’ spherical cups. To investigate these theoretical advantages and the potential 
influence of the quality of the acetabular bone, a clinical study was performed in patients 
with osteoarthritis (OA) and inflammatory arthritis (IA). The aims of the study were (1) to 
evaluate the fixation of the cup, postoperatively and later when osseous integration should 
have taken place, (2) to assess perioperative complications such as acetabular fractures 
and (3) to monitor the polar gap, a potential risk factor for osteolysis.
Patients and methods: A prospective study was performed on all consecutive OA and IA 
patients with an indication for primary total hip arthroplasty (THA). Three hundred and 
nine OA patients (340 hips) and 65 IA patients (76 hips) were included. The acetabular 
component was the flattened press-fit EPF-PLUS® cup, the femoral component the tapered 
cementless Zweymueller SL-PLUS® stem. All revisions and complications were recorded. 
Clinical and radiographical evaluation was performed on regular basis during 6–10 years. 
Results: The incidence of early loosening of the cup was 0 out of 340 in the OA group 
and 1 out of 76 in the IA group. The incidence of acetabular fractures was 7 out of 340 in 
the OA group and 3 out of 76 in the IA group. Failure rate for the acetabular component 
due to aseptic loosening or osteolysis after 6–10 years was 0% in the OA group and 4.8% 
in the IA group. In all cases available for follow-up the polar gap had disappeared and full 
osseous integration had taken place in both the groups.
Interpretation: This study shows that the flattened press-fit acetabular component creates 
adequate initial mechanical stability to allow osseous integration and that the cup can be 
safely used in both OA and IA patients. However, after 6–10 years, in the IA group failure 
of the cup due to aseptic loosening occurred once and failure due to osteolysis occurred 
three times, while these type of failures did not occur in the OA group. 
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Introduction
To improve the survival of cemented cups a newly designed cementless modular press-
fit acetabular component was introduced in our hospital, a reference centre for arthritis 
surgery, in 1996. The cup geometry with a flattened pole and a triple radius profile was 
designed to create a physiological load transfer to the pelvic bone providing sufficient 
bone contact with the rim of the acetabulum (Figure 5.1).
However, there are some concerns about the predefined gap that remains between the 
pole of the flattened cup and the hemispherically reamed acetabulum. This polar gap 
may be a potential space for accumulation of wear debris, macrophage proliferation, 
bone loss and osteolysis. Also, finite element studies have shown that during patient 
activity micromotion between the polar region of the cup and the acetabular floor can 
occur that may interfere with osseous integration [22, 23].
Furthermore, poor bone quality, as in patients with IA, affects the biomechanical 
properties of the bone, potentially compromising the quality of the initial fixation, and 
thus potentially compromising osseous integration [2-4, 19, 25]. On top of this, the 
risk of acetabular fractures during implantation could be increased. All these potential 
hazards may lead to early loosening of the cup especially in patients with IA.
Figure 5.1 Geometry of the acetabular component. Transverse section of the modular titanium 
EPF-PLUS® cup (Plus Orthopedics). The shell is characterized by a triple radius outer profile, 
thereby creating a gradual lowering of the polar part of the cup. Forces are mainly transmitted 
to the peripheral part of the acetabulum (R1). Contact stresses are gradually reduced in the 
transition zone (R2), leaving a gap between the cup and the bone in the polar zone of 1–2 mm 
(R3).
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To investigate these theoretical considerations and the potential influence of the quality of 
the acetabular bone on the fixation of the cup, a clinical study was performed in patients 
with osteoarthritis (OA) and inflammatory arthritis (IA). The aims of the study were (1) 
to evaluate the fixation of the cup, postoperatively and later when osseous integration 
should have taken place, (2) to assess perioperative complications such as acetabular 
fractures and (3) to monitor the polar gap, a potential risk factor for osteolysis.
Patients and methods
Patient characteristics
From February 1996 to December 1999 all consecutive primary THAs performed in 
patients diagnosed with primary OA, posttraumatic OA, and IA were included in the 
study. Informed consent was obtained from all patients and approval was obtained 
from the Review Board of the Slotervaartziekenhuis. Patients were classified into two 
diagnostic groups according to diagnosis. Three hundred and nine patients were classified 
as OA patients (340 hips: 281 primary osteoarthritis, 26 developmental dysplasia, 33 
posttraumatic), 65 patients were classified as IA patients (76 hips: 64 rheumatoid arthritis, 
3 juvenile inflammatory arthritis, 3 spondylitic arthritis, 6 miscellaneous). In the IA group, 
nine hips underwent a THA for either an acute proximal femoral fracture (six hips) or the 
sequelae of such a fracture (three hips).
Gender distribution was the same in both the groups but the IA group was significantly 
younger: mean age OA group 68.1 (SD 10.2), range 37–90; mean age IA group 58.5 (SD 
16.4), range 15–85 (p < 0.001). Preoperative Harris Hip score in the OA group was 45.7 (SD 
15.4), range 4–89, in the IA group 37.8 (SD 17.8), range 4–68. Distribution of the severity 
of the acetabular defects according to the classification of Paprosky [21] in the OA group 
was: grade 0, 335 (98%); grade I, 3 (1%); grade IIA, 2 (≤1%); grade IIB, 1 (≤1%); and grade 
III, 0. In the IA group this was: grade 0, 71 (93%); grade I, 3 (4); grade IIA, 1 (≥1%); grade 
IIB, 0; and grade III, 1 (≥1%). Distribution of the severity of the arthritic changes in the 
IA hips according to Larsen [15] was: grade 0, 1 (1%); grade I, 4 (5%); grade II, 4 (5%); 
grade III, 15 (20%); grade IV, 51 (67%); and grade V, 1 (1%).
Implant
The acetabular component used was the modular EPFPLUS® cup (Plus Orthopedics AG, 
Rotkreuz, Switzerland). It consists of a titanium shell characterized by a triple radius outer 
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profile, thereby creating a gradual lowering of the polar part of the cup (Figure 5.1). For 
improvement of the press-fit fixation and to deal with any extra bone removed during 
hemispherical reaming, in general 0.5 mm [16], the diameter of the cup is 1 mm larger 
than the diameter of the reamer, e.g., a cup size 50 in reality measures 51 mm in diameter. 
In order to enhance osseous integration, the outer surface of the component is coated with 
a double ground layer of pure titanium which is porous. On top of this porous titanium 
layer a 50- m layer of a crystalline hydroxyapatite is applied. In all cases a 28-mm ball 
head was used. Routinely, a polyethylene liner was used, paired with a zirconia ceramic 
ball head. In some young patients (mean age 46.5, range 28–59) a metal-in-polyethylene 
insert in combination with a metal ball head (both made from Sikomet SM21 low-carbon 
alloy; Plus Orthopedics) was chosen as the bearing combination. The femoral component 
used was the SL-PLUS® stem, the latest version of the cementless tapered press-fit stem 
according to Zweymueller (Plus Orthopedics).
Surgical technique
A lateral approach, either a transgluteal or an anterolateral, was used routinely for exposure 
of the hip joint, independently of the preoperative diagnosis. However, on two occasions 
an osteotomy of the greater trochanter was performed to improve the exposure to the 
acetabulum, while on three occasions a posterior approach was used (in one hip because 
of a contra lateral stiff hip and in two hips because severe acetabular deficiency required 
an advanced exposure).
Routinely a non-oversized acetabular component was inserted. However, when the stability 
of the trial shell was judged to be insufficient, depending on the preference of the surgeon, 
either an oversized component was implanted or augmentation of the fixation with one 
or two screws was carried out. The central gap between the shell and the acetabulum 
was routinely grafted with bone slurry from the biggest acetabular reamer that had 
been used.
Postoperatively, patients were allowed to walk with weight bearing to tolerance from the 
second day onwards, usually using two crutches for 6 weeks, then one crutch for another 
6 weeks. The rehabilitation program was the same for IA and OA patients.
There were no differences between the OA and the IA group concerning surgical technique 
or fixation method of the acetabular component; transgluteal approach (56 and 55%, 
respectively), use of an oversized cup (19 and 18%, respectively), or augmentation with 
screw fixation (20 and 25, respectively). 
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Clinical evaluation
Patients were evaluated preoperatively and followed postoperatively at 3 and 12 months 
and then annually. Assessment was performed using the Harris Hip Score [12] and by 
a subjective evaluation grading patient satisfaction into three categories: unsatisfied, 
satisfied and very satisfied. All local and general complications as well as all re-operations 
and revisions were recorded. In all deceased patients this information was obtained by 
contacting relatives and the general practitioner.
Radiographic evaluation
Radiographs of the hip joints were obtained preoperatively, immediately postoperative 
and at the regular follow-up visits according to a standard protocol. Preoperative arthritic 
changes in the IA hips were classified according to Larsen [15] and acetabular defects 
classified according to Paprosky [21]. Inclination of the acetabular component was 
determined by measuring the angle between the inter-teardrop line of the pelvis and a line 
through the opening plane of the component. Malposition of the component was defined as 
either a perforation through the acetabular floor or a position more than 1 cm too cranial 
to the anatomical acetabulum, or an inclination of the component of more than 55° or 
less than 40°. Acetabular component migration was defined as a change in the vertical or 
horizontal position of more than 3 mm or a change in the inclination of the component of 
more than 5° on comparable radiographs, as measured using the criteria of Massin [17]. 
Radiolucent lines around the cup were assessed according to the method of DeLee [8] 
dividing the acetabulum in three zones. Osteolytic lesions in the acetabulum and proximal 
femur were recorded. An acetabular component was defined radiographically loose if it had 
migrated or was completely surrounded with a radiolucent line 2 mm or more in width.
The gap created between the polar part of the cup and the floor of the acetabulum was 
assessed for the signs of bony ingrowth, radiolucent lines, or the occurrence of osteolytic 
lesions. Heterotopic ossification was evaluated by the method of Brooker [5].
Statistical methods
The two diagnostic groups were compared either by using the Fisher exact test or the Chi-
Square test for 2 × 2 tables whenever the outcome was a dichotomous variable (and no 
time component was involved); the Student t-test in case of continuous outcome variables; 
or a survival approach using Kaplan-Meier [13] estimates and Cox proportional hazards 
models in the case of a dichotomous outcome as a function of “time since operation”. In 
all cases p-values < 0.05 were considered statistically significant.
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The probability of implant survival was estimated by Kaplan-Meier survival analysis in 
both the diagnostic groups. The survival analyses were performed twice: once for failure 
of the cup due to any cause and once for failure of the cup due to aseptic loosening. In this 
case failure to another cause than aseptic loosening was treated as a censoring event in 
the Kaplan-Meier or Cox model, just as death and patients lost to follow-up. Since aseptic 
loosening and ‘non-aseptic loosening’ are actually ‘competing risks’ and together define the 
event ‘overall failure’, the Kaplan-Meier estimates are themselves incorrect for the purpose 
of estimating the true probabilities in the population. Although the relative risks comparing 
the two diagnostic groups are estimated correctly, the survival curves themselves should 
be calculated by a competing risk method, for which the package NCSS 2000 was used. 
In such a competing risk context, the sum of the survival curves for aseptic loosening and 
non-aseptic loosening add up exactly to the overall survival curve. The relation between 
the diagnostic group and the risk of failure is estimated in the Cox framework. The log-
rank test was used to compare the survival curves of the two diagnostic groups.
All data were stored in a database developed for data management in prosthetic surgery 
(Project Manager version 7.0, department of medical statistics LUMC, Leiden, The 
Netherlands). This program was linked to SPSS version 11.5 (SPSS Inc, Chicago, Illinois) 
for the statistical analysis.
Results
Complications
Fractures of the acetabular rim occurred in the OA group in four cases (1%) and in the 
IA group in two cases (3%). Fractures of the acetabular floor due to protrusion of the cup 
occurred in the OA group in three cases (1%) and in the IA group in one case (1%). None 
of the fractures required further treatment; all healed well with good fixation of the cup. 
Malposition of the cup in too much inclination (more than 55°) occurred in the OA group 
in twenty-three cases (6%) and in the IA group in eight cases (10%). Malposition of the cup 
in inclination less than 40° occurred in the OA group in thirty cases (9%) and in the IA 
group in eight cases (10%). Malposition of the cup in a too cranial position occurred in the 
OA group in one case, and none in the IA group. Two cups in the IA group with increased 
inclination developed PE wear and osteolysis and are discussed below. Except for these two 
all other malpositioned cups were well fixated and did not require additional treatment.
No significant differences were found between the diagnostic groups with respect to the 
incidence of the complications.
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Dislocations occurred more frequently in the IA group than in the OA group; ten cases 
(3%) in the OA group, seven cases (9%) in the IA group (p < 0.001).
Cup revisions (Table 5.1)
Six acetabular components were revised in the OA group; four for infection and two for 
recurrent dislocation. In the infected hips a successful two-stage revision of both the 
components was carried out.
In the IA group five acetabular components were revised; one for infection, one for early 
mechanical failure, and three for osteolysis of the pelvic bone. In the infected hip both 
the components were removed 2 months after implantation. This patient died due to 
multi-organ failure before the second stage of the revision surgery could be performed. 
The cup that was revised for early mechanical failure tilted after a fall on the hip 4 months 
postoperatively. In this case, apart from the grade IV degenerative changes the preoperative 
radiographs showed a roof defect, classified as Paprosky stage 3A (Figure 5.2). Two cups 
Figure 5.2 (A) Pre-operative ap-radiograph in a 67-year-old male patient with IA and severe 
degenerative changes (grade IV). A defect on the superior lateral aspect of the acetabular roof 
is made visible with the use of a template on the radiograph. (B) Post-operative ap-radiograph. 
The defect on the superior lateral aspect of the acetabular roof has been grafted. (C) Four 
months after the operation the patient suffered a fall on the left thigh, thereby tilting the cup, 
necessitating an early revision.
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that were revised for osteolysis concerned the same patient; a teenaged girl with juvenile 
idiopathic arthritis, who had undergone bilateral total hip arthroplasty. Both the cups 
had been implanted with an increased abduction angle (more than 55°) and developed 
polyethylene wear and osteolysis, necessitating revision after 85 and 97 months, respectively. 
The third cup with osteolysis was in a 35-year-old male patient diagnosed with Still’s disease. 
The metal insert became unstable causing metallosis and osteolysis. Revision of this cup 
was performed 84 months after the initial operation. All three cups were stable in the first 
years postoperative with filling of the polar gap and no radiolucencies.
Re-operations other than revisions of the cup
Recurrent dislocations necessitated an insert exchange in one IA patient leaving the shell 
in place; the neutral insert was exchanged for a snap-fit insert.
One femoral component required revision for aseptic loosening 2 years after surgery in a 
70-year-old male patient with IA.
Clinical and radiographical results
At a latest follow-up in September 2006, 344 cases (287 OA, 57 IA) were available for 
clinical and radiographical assessment. In the OA group 37 patients (38 hips) had died, 
eight patients (9 hips) were lost to follow-up. In the IA group 13 patients (14 hips) had 
died, onepatient (1 hip) refused further follow-up after 2 years.
Neither one of the deceased patients nor the patients lost to follow-up were known to 
have any problem related to the hip replacement surgery. In none of the deceased patients 
there was a relation between the operation and the cause of death. Both deceased patients 
and patients lost to follow-up were included in the results. The mean follow-up was 70.8 
months (SD 13.1), range 48–109 in the OA group, and 69.2 months (SD 12.2), range 48–99 
in the IA group.
Clinical results
In both the diagnostic groups the Harris hip score improved significantly; in the OA group 
from 45.7 (SD 15.4), range 4–89 preoperatively to 90.9 (SD 11.8), range 34–100 at follow-
up, in the IA group from 37.8 (SD 17.8), range 4–68 to 88.5 (SD 13.1), range 51–100. The 
vast majority of patients had an excellent or good score (OA group 86%, IA group 82%), 
had no pain (OA group 77%, IA group 69%) and were satisfied with the result (OA and 
IA group 94%).
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Radiographical results
The polar gap disappeared and full osseous integration took place in all the components 
of both the groups (Figure 5.3).
In the OA group one acetabular component developed a radiolucent line in zone 1 with 
a width of 1 mm. This line was first detected 34 months after the operation and was not 
progressive until the last follow-up at 93 months postoperatively. In one case an isolated 
osteolytic lesion developed in the super part of the acetabulum without signs of progression 
63 months after surgery.
In the IA group two cups showed radiolucent lines. One of these had lines of 1 mm in 
both zone 2 and zone 3. The lines were first detected at 14 months postoperative. These 
had not progressed at the last follow-up at 61 months. The other acetabular component 
showed radiolucent lines of 1 mm in all three zones. These were first detected at 49 months 
and were not progressive at last follow-up at 77 months. Three femora showed an isolated 
osteolytic lesion in the calcar region without signs of progression, respectively, 62, 85 and 
96 months after surgery.
Figure 5.3 (A,B) Postoperative antero-posterior and lateral radiographs with visible polar gap. 
(C,D) Antero-posterior and lateral radiograph 12 months postoperative; the gap has disappeared, 
and full bony ingrowth has occurred.
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There were no acetabular components with signs of migration or changes in the cup angle, 
subsequently none were diagnosed to be loose. Severe heterotopic ossifications (Brooker 
III or more) were seen only in few hips with no differences between the two groups: three 
cases in the OA group and one in the IA group.
Survival
Survival of the acetabular component at 7 years (84 months) with osteolysis and/or aseptic 
loosing loosening as the end point in the OA group was 0.99 [standard error (SE) = 0.006], 
and in the IA group 0.93 (SE = 0.05). 
Figure 5.4 (A) Survival curves visualized on the basis of cumulative incidence estimates of 
failure of the acetabular components in a competing risk setting. (B,C) Cumulative incidence 
of failure of the acetabular components in a competing risk setting, by diagnostic group (B IA 
group; C OA group). X axis: time in months since operation. Y axis: probability of failure. Dark 
grey area: probability of failure due to aseptic loosening or osteolysis. Light grey area: probability 
of failure due to other causes such as infection and recurrent dislocation.
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The failure rate for the acetabular component due to osteolysis and/or aseptic loosing 
loosening was 0% in the OA group and 4.8% in the IA group.
The cumulative probability of failure split for osteolysis and/or aseptic loosening and other 
causes of component failure such as infection and recurrent dislocation are presented 
in Figure 5.4a. The cumulative incidences of failure of the acetabular components in a 
competing risk setting split per diagnostic group are given in Figure 5.4b.
Discussion
Cemented acetabular components have become the restrictive factor in the long-term 
survival of THA, especially in patients with IA [6, 7, 26, 28]. When introducing a newly 
designed implant to improve these long-term results, early evaluation is of importance 
for the detection of design errors, complications and failures. Especially in the case of a 
cementless prosthesis, radiographic signs of loosening are visible at an early stage when 
osseous integration has failed [18]. The medium-term results in this study with use of a 
flattened acetabular component are comparable to several publications on cups with use 
of a fully hemispherical geometry used in OA patients [9, 10, 20]. Therefore, it can be 
concluded that the primary stability of the flattened cup is sufficient for osseous integration. 
The flattened profile has, compared to hemispherical cups, the advantage of creating a more 
physiological load transfer from the implant to the pelvic bone transmitting forces to the 
peripheral part of the acetabulum [27]. Compared to spherical cups with a ‘low-profile’ 
(smaller than a hemisphere), the triple radius profile creates increased contact between 
the cup and the periphery of the acetabulum. These ‘low-profile’ cups have shown to be 
less stable compared to true hemispherical cups when inserted in a foam model due to 
the decreased contact area between the cup and bone [1].
Complications
In the IA group one cup suffered an early mechanical failure while no early mechanical 
loosening was seen in the osteoarthritis group. Two additional factors have led to this early 
failure: a defect of the superolateral acetabular roof (Figure 5.2) and a fall on the hip. All 
other cups were stable and showed good osseous integration in all three zones apart from 
two cups in the IA group with radiolucent lines in two and three zones, respectively. The 
width of these lines did not exceed 1 mm and were not progressive up to the last follow-
up. The incidence of intra-operative fractures of the acetabulum did not differ between 
the two groups. All fractures healed well without additional treatment.
72
THA with a flattened cup in OA and IAChapter 5
Polar gap
Our clinical and radiographic results neither confirm the theoretical concerns on polar 
gaps as being a potential space for accumulation of wear debris, macrophage proliferation, 
bone loss and osteolysis, nor that apposition of bone in the polar gap region is compromised 
due to micromotion [22, 23]; the initial gap between the dome of the acetabulum and the 
cup filled itself rapidly with trabecular bone during the process of osseous integration.
Inﬂ ammatory arthritis
IA is associated with altered biological and mechanical properties of the bone caused 
by osteopenia and increased bone turnover, leaving less mineralized bone [2–4, 19]. 
Furthermore, the properties of the bone are affected by the medication IA patients need to 
take [2]. The affected quality of the bone could lead to complications such as insufficient 
initial stability of the cup in the acetabulum, inadequate osseous integration and fractures 
of the acetabulum during implantation. Three cups in the IA group were revised due to 
osteolysis in the pelvic bone, in contrast to none in the OA group. Two of these cups 
developed osteolysis in combination with wear of the polyethylene insert in cups that were 
inserted too steep, the third cup suffered from an unstable metal insert causing metallosis.
Studies on press-fit cups in IA patients are scarce. Three reports on THA in IA patients 
using an uncemented hemispherical cup show similar results; Thomason and Lachiewicz 
[24] found two cases of aseptic loosening out of 98 hips after a mean follow-up of 7.4 
years. No cases of aseptic loosening were found by Effenberger et al. [11] in 31 cases 
after a mean follow-up of 4.1 years and none by Katsimihas et al. [14] in 82 cases after 
a mean follow-up of 9.1 years. In contrast to these three studies in which screw fixation 
was performed routinely, screw fixation in our study was only used when initial stability 
during the operation was thought to be insufficient.
Conclusions
This study shows that in both OA and IA patients the flattened press-fit EPF-PLUS® 
acetabular component is a safe implant creating adequate initial stability in the acetabulum 
to allow osseous integration and filling of the polar gap region. The risk of fractures of the 
acetabulum does not seem to be a significant problem in the IA group.
However, after 6–10 years, in the IA group failure of the cup due to aseptic loosening did 
occur once and failure due to osteolysis did occur three times while these type of failures 
did not occur in the OA group. Due to the large differences between OA patients and IA 
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patients and the low incidence of aseptic loosening of the cup it is not clear if failure is 
related to the inflammatory arthritis disease or to the additional factors that occurred in 
all four failed cups (acetabular defect, malposition of the cup or unstable insert).
It seems that as long as acetabular bone stock is sufficient and positioning of the cup is 
adequate loosening of the cup can be prevented in both the diagnostic groups.
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Abstract
Background: It is unclear whether patients with inflammatory arthritis have a higher risk 
of dislocation after hip replacement.
Patients and material: We carried out a prospective study assessing the incidence of 
dislocation within 2 years after surgery for patients diagnosed with inflammatory arthritis 
(IA) and osteoarthrosis (OA). One single type of prosthesis was implanted using a lateral 
approach. Both diagnostic groups were compared by univariate analysis with respect to 
dislocation, sex, age, diagnosis, prior hip surgery, experience of the surgeon and malposition 
of the acetabular component. In a multivariate logistic regression approach, the difference in 
dislocation incidence was assessed after adjusting for the effect of the potential confounders 
given above. Between 1996 and 1999, 410 THA were performed: 70 in IA and 340 in OA. 
After 2 years no patients were lost to follow-up, but 12 patients had died, and five revisions 
were carried out for reasons other than dislocation. 
Results: The dislocation rate in patients with IA was higher than in patients with OA: 10% 
(7 hips) in the IA group and 3% (10 hips) in the OA group (p = 0.006). No significant 
differences were found among the risk factors for dislocation between the two groups. 
Multivariate logistic regression analysis showed that IA is an independent risk factor for 
dislocation (odds ratio (OR) 3.7, 95% CI 1.3–11), together with malposition of the cup 
in more than 55º abduction (OR 7.7, CI 2.3–26) and increased anteversion (OR 7.6, CI 
1.4–42.4).
Interpretation: Our findings clearly suggest that inflammatory arthritis has to be consid-
ered as an independent risk factor for dislocation after primary THA. 
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Introduction
Dislocation is one of the most frequent early complications of total hip arthroplasty 
(THA) and may lead to prolonged hospitalization, and even to surgical reintervention. 
The incidence of dislocation after primary THA has been reported to range from less 
than 1% to greater than 10% [9, 12, 24, 28, 43]. The cause of dislocation is known to be 
multivariate and risk factors can be differentiated into patient-related, prosthesis-related 
and surgery-related factors. Patient-related risk factors are prior hip surgery [10, 32, 41], 
old age [3, 10, 29], high American Society for Anaesthesiologists score [18], female sex 
[21, 39, 41] and excessive alcohol consumption [42]. However, there is no consensus on 
whether patients with inflammatory arthritis (IA) have a higher risk of dislocation. Some 
authors have reported a higher dislocation rate in IA [1, 2, 8, 13], while other reports have 
shown no significant difference in dislocation rate between IA and osteoarthrosis (OA) [4, 
16, 34, 41]. To determine whether inflammatory arthritis is an independent risk factor for 
dislocation, we conducted a prospective observational study comparing the incidence of 
dislocation in IA and OA patients in the first 2 years after primary THA.
Patients and methods
All operations were carried out at our hospital, which is both a teaching hospital and 
a reference centre for arthritis surgery. Between January 1996 and December 1999, 
all consecutive patients receiving a primary THA for both primary or posttraumatic 
osteoarthrosis and inflammatory disease (mainly rheumatoid arthritis) were included 
in the study. Patients with other diagnoses such as avascular necrosis, tumors, juvenile 
idiopathic arthritis and ankylosing spondylitis, were excluded from this study. 
In all cases, an uncemented EPF-PLUS press-fit titanium acetabular component with a 
neutral polyethylene liner and an SL-PLUS press-fit titanium femoral component were 
used (PLUS Endoprothetik AG, Rotkreuz-CH). The SL-PLUS stem is the latest version 
of the cementless tapered press-fit stem according to Zweymüller (Figure 6.1). A 28-mm 
head was used in every case.
All operations were carried out in supine position and a lateral approach was used 
routinely; either anterolateral, or transgluteal. A trochanteric osteotomy was used only 
once in a rheumatoid hip with an ipsilateral stiff knee. Two hips in the OA group had 
a posterior approach; one because of a contralateral hip arthrodesis and one because of 
destruction of the acetabulum. The rehabilitation program was similar for all patients: at 
2 days postoperatively, they were mobilized on crutches with weight bearing to tolerance, 
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full weight bearing generally being allowed 6 weeks after surgery. More than 90 degrees 
flexion of the hip was prohibited in the first 6 weeks, as were adduction and combined 
flexion and internal rotation; therefore, turning in bed was only allowed with a pillow 
between the knees.
Clinical data were collected according to a standard protocol, including physical 
and radiographic examination preoperatively, and at 3 months, 1 year and 2 years 
postoperatively. All first dislocations and other major complications that occurred 
within 2 years after surgery were recorded. The following risk factors were evaluated: 
age, sex, diagnosis, incidence of previous surgery, surgical approach and malposition 
of the acetabular component (Table 6.1). Experience of the surgeon was evaluated by 
differentiating between operations carried out by registrars – all having performed less than 
50 THAs – and orthopedic consultants who had carried out considerably more than fifty 
Figure 6.1 (A) Adequate positioning of the prosthetic components in a 76-year-old woman 
with rheumatoid arthritis. (B) 4 weeks after surgery, the hip dislocated while sitting on the edge 
of her bed.
A B
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THAs. Furthermore, we evaluated stem size, the direction of dislocation, the mechanism 
of dislocation and the interval between surgery and dislocation, as well as redislocation 
and reoperation.
Radiographic evaluation
The abduction angle of the acetabular component was determined on standarized 
anteroposterior radiographs of the pelvis centred over the symphysis pubis, according 
to a method described by Woo and Morrey [41]: the angle between a line parallel to the 
opening of the shell and a line through the lower edges of both the ischial tuberosities. We 
defined malposition as an abduction angle of more than 55°.
Acetabular anteversion was estimated on lateral cross-table radiographs with the patient 
supine and the contralateral hip flexed to 90°. The anteversion angle was obtained by 
measuring the angle between a line tangential to the face of the cup and a line perpendicular 
to the horizontal plane. These measurements cannot be considered to be absolute values, 
but allow an estimation of excessive anteversion or retroversion. Despite the shortcomings 
of this technique, it has been used by many authors through the years [6, 18, 28, 32, 41, 
42]. We defined malposition either as retroversion or anteversion of more than 20°.
A protrusion position of the cup was defined as contact with or perforation through the 
ilioischial line on the anteroposterior pelvic radiograph.
Table 6.1 Potential risk factors for dislocation analyzed with univariate, multivariate and 
survival analysis
Female sex
Age over 80 years
Inflammatory arthritis
Earlier hip surgery
Surgical experience of the surgeon (registrars versus consultants)
Surgical approach (anterolateral versus transgluteal)
Malposition of acetabular component
More than 55 degrees of abduction
More than 20 degrees of anteversion 
Retroversion
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Statistics
For univariate comparisons of the two diagnostic groups with respect to dichotomous 
variables, Fischer’s exact test or Mann-Whitney U test was used. The Student t-test was 
used for comparison of continuous variables. We used multivariate analysis on the total 
patient population, adjusting the difference in probability of dislocation between the two 
diagnostic groups for differences in the potential risk factors for dislocation as listed in 
Table 6.1. Because some patients were bilaterally operated (and hence to account fully for 
the interdependency of part of the observations), we used a (distinguishable binomial) 
random effects logistic regression model. In this context, patients with less than 2 years of 
follow-up had to be excluded, however; they correspond to “censored” cases in a survival-
like context. To verify that the exclusion did not bias the results, we also performed a 
normal survival analysis in which these patients were included as censored observations, 
the endpoint again being “dislocation” (in which case, all bilaterally operated patients were 
simply counted as two observations). Both the odds ratio (OR) in the logistic regression 
context and the hazard ratio (HR) in the Cox-regression survival context were calculated 
as estimates of the relative risk of dislocation between the two diagnostic groups.
Univariate analyses were carried out using SPSS software (SPSS Inc., Chicago, Illinois). 
Random effects and Cox models were fitted to the data using EGRET for Windows (version 
2.0.3, 1999).
Results
Between 1996 and 1999, 410 hip replacements were performed in 371 patients: 70 hip 
replacements in IA patients and 340 in OA patients (Table 6.2). At 2 years, no patients 
were lost to follow-up. Twelve patients (12 hips) had died. One of the deceased patients 
suffered a dislocation 9 months after surgery for OA; she died 3 months later of a cause not 
related to the THA or dislocation. Five hips were revised for reasons other than dislocation.
Comparison of the two diagnostic groups showed no significant differences regarding the 
following risk factors: sex, previous hip surgery, experience of the surgeon and surgical 
approach. However, the risk factor age was significantly higher in the OA group (p < 0.001).
The dislocation rate was higher in the IA group than in the OA group (Table 6.3). The 
incidences of malposition of the cup and revision rate did not differ between the two 
diagnostic groups.
By using a multivariate stepwise backwards logistic regression analysis, three risk factors for 
dislocation could be identified: (1) position of the cup in more than 55 degrees of abduction 
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(OR 7.7, 95% CI 2.3–26), (2) position of the cup in more than 20 degrees of anteversion 
(OR 7.6, CI 1.4–42), and (3) inflammatory arthritis (OR 3.7, CI 1.3–11). Adjusted for age 
and sex, these values are comparable for all three: increased cup abduction (OR 7.0, CI 
2.2–23), increased cup anteversion (OR 8.1, CI 1.4–45) and inflammatory arthritis (OR 
3.9, CI 1.3–11.8). Multivariate analysis including the 12 deceased patients (but disregarding 
their shorter time-at-risk) showed similar odds ratios.
Multivariate survival analysis (Cox) with backward elimination and dislocation as the 
endpoint gave the same three risk factors for dislocation: increased cup abduction (HR 
5.9, CI 2.0–17), increased cup anteversion (HR 5.8, CI 1.3–27) and inflammatory arthritis 
(HR 3.0, CI 1.1–7.8). Univariate analysis showed similar results, indicating that the risk 
factors were distributed equally over both diagnostic groups and that there was no mutual 
confounding among the three risk factors.
Table 6.2 Demographic data
Osteoarthritis Inflammatory arthritis
Operated patients 311 60
Operated hips 340 70
Mean age (years)a
(range)
68 SD 10
38–90
61 SD 14 
27–85
Female / male (%) 78 / 23 73 / 28
Diagnosis (hips)                  
Primary OAb 282
DDHc 25
Posttraumatic OA 33
Seropositive RAd 17
Seronegative RAe 47
Adult-onset Still  4
Psoriatic arthritis 1
Mb. Sjögren 1
Number of hips with prior hip surgery 29 (9%) 3 (4%)
Number of hips operated by registrars 62 (18%) 12 (17%)
Surgical approach
Posterior 2 –
Anterolateral : transgluteal 146 : 192 30 : 40
a Student t-test: p < 0.001
b OA: Osteoarthritis
c DDH: Developmental dysplasia of the hip 
d Rheumafactor positive rheumatoid arthritis
e Rheumafactor negative rheumatoid arthritis
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Data concerning dislocated hips (Table 6.4)
Of the 10 patients in the OA group who suffered a dislocation, two had had prior hip 
surgery, two had an abduction of the cup of more than 55°, one had an anteversion angle 
of more than 20° and two were of traumatic origin.
Of the seven patients with dislocation in the IA group, none had had prior hip surgery, 
one hip had an abduction angle of the cup of more than 55°, one had an anteversion 
angle of more than 20° and there were no traumatic dislocations. The smallest stem that 
dislocated was size 3; all other six stems had size 4 or larger. None of the dislocated hips 
in this group had a protrusion position of the cup. Nearly half of the dislocations in the 
OA group were anterior while in the IA group all dislocations were posterior. There were 
no bilateral dislocations.
All dislocated hips could be treated by closed reduction, except for one case that was 
diagnosed late. In this case, closed reduction failed and a reoperation was performed with 
revision of the acetabular component. Five of 17 dislocated hips (3 OA, 2 RA) suffered a 
redislocation; three of these (2 OA, 1 RA) required a reoperation. After reoperation, the 
two OA patients had a stable hip and the RA patient required a snap-fit insert to stabilize 
the hip.
Table 6.3 Position of the cup, incidence of dislocation and revision for any reason, for both 
diagnostic groups
Osteoarthritis
340 hips
n (%)
Inflammatory arthritis
70 hips
n (%)
Rotational position of the cup
Abduction > 55° 23 (6.8) 7 (10)
Anteversion > 20° 8 (2.4) 3 (4)
Retroversion – –
Protrusion position of the cup
Perforation through ilioischial line 2 (0.6) –
Contact with ilioischial line 31 (9.1) 4 (6)
Dislocationa 10 (2.9) 7 (10)
Revisions for any reason 4 (1.2)b 3 (4)c
a Statistically significant difference between osteoarthritis group and inflammatory arthritis group (chi-square 
test: p = 0.006).
b 3 revisions carried out for infection; 1 for recurrent dislocation.
c 1 revision carried out for aseptic loosening of the acetabular component; 1 for infection, and 1 for late-diagnosed 
dislocation.
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Discussion
Studies on the incidence of dislocation after THA are difficult to compare because of 
differences in patient selection, follow-up time [2], number of dropouts and in the method 
of obtaining data [14]. Furthermore, there are differences in risk factors such as posterior 
surgical approach [23, 28, 41], prosthetic design [4, 9, 20, 37, 39] and experience of the 
surgeon [11, 17]. To our knowledge, this is the first study evaluating prospectively the risk 
of dislocation after THA, comparing a group of patients with OA and a group of patients 
with IA while using one type of prosthesis and a lateral surgical approach routinely.
Patient-related risk factors
Between the two diagnostic groups, no differences could be found in the patient-related 
risk factors, except that the OA group had a higher age, a risk factor for dislocation. 
Despite this, the IA group had a higher incidence of dislocation. In both groups in our 
study population, there were significantly more female than male patients in both groups. 
This gender distribution is comparable with the population in the study of Hedlundh et 
al. [15] and that of Ostendorf et al. [31]. The latter study describes the epidemiology of 
Table 6.4 Data concerning dislocated hips
Osteoarthritis Inflammatory arthritis
Number of dislocated hips 10 7
Direction of dislocationa
Anterior 4 –
Posterior 5 7
Unknown 1 0
Mechanism of dislocation
Traumatic 2 –
Non-traumatic 6 6
Unknown 2 1
Interval after surgery
Within 3 months 8 6
After 3 months 2 1
Redislocation 3 2
Reoperation for persistent instability 2 b 1c
a Fisher exact test: p = 0.088.
b Reoperations: 1 revision of the cup; 1 ball head exchange.
c Reoperations: snap-fit insert.
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total hip replacement in the Netherlands. To exclude a gender/age bias in our study, the 
multivariate analysis was repeated including sex and age.
Malposition of prosthetic components
Cup orientation has been shown repeatedly to be a critical variable related to instability [12, 
18, 22, 36], but only severe malposition of the components seems to affect the dislocation 
rate [5, 11, 25, 26, 33]. According to Lewinnek et al. [25] and Pierchon et al. [33], anterior 
dislocation is associated with increased anteversion of the acetabular component. However, 
there was no correlation in these studies between cup orientation and posterior dislocation 
– the commonest direction of dislocation in our IA group. Both authors infer that optimal 
orientation (15 ± 10 degrees anteversion and 40 ± 10 degrees abduction) of the acetabular 
component will not necessarily prevent posterior dislocation. Both multi- and univariately, 
an increased abduction angle and anteversion angle were associated with dislocation but 
none of them were confounders for the relation between the diagnosis and dislocation.
Rheumatoid arthritis as a risk factor
The literature is not conclusive on this subject. Few studies have reported increased rates 
for dislocations in patients with RA. Hedlundh et al. [15] noticed an increased risk ratio 
of 1.8 for rheumatoid arthritis compared to osteoarthrosis in more than 3000 Charnley 
hip arthroplasties. However, when material from another three centers with approximately 
3000 Lubinus arthroplasties was added, the difference was no longer significant [16]. 
Creighton et al. [8] described an 11% dislocation rate in 103 cemented THAs in patients with 
rheumatoid arthritis. All operations were performed by one surgeon through an anterior 
approach with an osteotomy of the greater trochanter. However, two types of prosthesis 
were used: either a Charnley stem with a 22.25-mm diameter head or an Iowa stem with a 
28-mm diameter head. There was no control group for comparison and no comment was 
given on the cause of this elevated dislocation rate. Arnold et al. [1] described an increased 
risk for dislocation in patients with rheumatoid arthritis. They related this to the posterior 
approach that was used in most rheumatoid hips, in contrast to the anterior approach that 
was used in most patients with osteoarthrosis. Berry et al. [2] performed a retrospective 
study on more than 6000 Charnley THAs operated in the Mayo clinic between 1969 and 
1984. The report provides information on the long-term risk of dislocation after THA. 
Multivariate analysis revealed that the 445 patients (622 hips) with IA had a mildly elevated 
risk of dislocation compared with the 3498 patients (4279 hips) who had OA (relative risk 
1.5, 95% CI, 1.0–2.1, p = 0.04).
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Other studies have not shown a significant difference in dislocation rate between OA and 
IA patients. In a retrospective study by Poss et al. [34], of 275 THAs on 205 patients with 
rheumatoid arthritis and 382 THAs on 305 patients with osteoarthrosis, no difference 
was found in the rate of dislocation: five in each group. In another retrospective study, 
Woo and Morrey [41] observed no difference in dislocation rate: 3.5% in 481 THAs in 
patients with rheumatoid arthritis compared to 2.3% in 5924 patients with degenerative 
arthritis. 
Byström et al. [4] analyzed 42987 primary hip replacements from the Norwegian Arthro-
plasty Register to determine risk factors for dislocation leading to revision. Only femoral 
head size was found to be a risk factor; and there was no increased risk for patients with 
RA. However, the authors state that it is still possible that dislocations are commoner in 
RA patients than in OA patients due to the fact that only revisions were recorded, and not 
the dislocations that were treated nonoperatively or by insert exchange.
There have been other studies considering the postoperative complications in rheumatoid 
arthritis patients after THA (but without a control group) which have not reported increased 
risk of dislocation [7, 19, 27, 30, 35, 38, 40]. Our study clearly suggests that inflammatory 
arthritis must be considered to be an independent risk factor for dislocation after primary 
THA.
Considerations
The 10% dislocation rate for IA patients that we have found is unacceptably high. There 
have been no previous reports available concerning the reasons why rheumatoid arthritis is 
a risk factor for dislocation. The inferior quality of the soft tissues (due to the rheumatoid 
arthritis) probably leads to inadequate soft tissue tension. Another factor may be the 
concomitant impairments in rheumatoid patients. Impairments of the upper extremity, 
ipsilateral knee and ankle or contralateral hip can lead to hyperflexion of the operated hip 
while rising from a chair, or during other activities of daily living.
To reduce the risk of dislocation in patients with rheumatoid arthritis, we suggest the 
following measures: (1) careful intraoperative soft tissue handling to preserve the stabilizing 
structures of the hip joint, (2) consideration should be given to the use of an acetabular 
component with an elevated rim in cases where the hip is not fully stable at the time of 
surgery, to prevent posterior dislocation, and (3) special attention during the postoperative 
rehabilitation program to prevent hyperflexion of the operated hip.
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Abstract
Background: Cemented total hip arthroplasty (THA) in rheumatoid arthritis (RA) is 
allegedly associated with increased rates of infection, dislocation and aseptic loosening 
of cup and stem relative to THA in osteoarthritis (OA).
Method: Systematic review of the literature on clinical and radiological results of cemented 
THA in RA. 
Results: Twenty-one case series and eight reports on four implant registries were included. 
The quality of most studies was judged to be poor. The reported rates of infection and 
dislocation in the case series were conflicting with a risk of bias due to under-registration. 
The registries proved to be unsuitable for providing reliable data on the incidence of these 
two complications. Increased rates of aseptic loosening were reported in ten out of twenty 
case series on the cup and in six out of nineteen on the stem. Nearly all of these were based 
on series implanted before 1980. None of the registries reported a significantly increased 
risk of aseptic loosening of cup or stem.
Conclusions: Considering the relatively frequent reports of increased infection rates in 
combination with the potential under-registration of complications, RA patients have to 
be considered to have a mild increased risk for post-operative infection. Since case series 
and registries cannot answer the question of whether RA is a risk factor for dislocation, 
multivariate analysis is required. Increased rates of cup and stem failure due to aseptic 
loosening in RA patients are found in older but not in more recent studies. 
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Introduction
Total Hip Arthroplasty (THA) in Rheumatoid Arthritis (RA) patients has been associated 
with a decreased likelihood of a favourable outcome and higher complication rates [28, 
34, 35, 42, 62, 78, 81]. Polyarticular involvement, young age, compromised biomechanical 
properties of both soft tissue and bone, and influence of medication are potential risk 
factors for a positive end result.
This systematic literature review was conducted to investigate the results of cemented 
THA in RA patients, with a special emphasis on the rates of infection and dislocation and 
aseptic loosening of cup and stem. The research questions formulated were: (1) What are 
the reported rates of post-operative infections after THA in RA patients? (2) What are the 
reported rates of post-operative dislocations after THA in RA patients? (3) What are the 
failure rates of cemented cups and stems with aseptic loosening as endpoint compared to 
the criteria of the National Institute of Clinical Excellence (NICE)?
Methods
The systematic review was performed using methodology and checklists on search 
strategy, methods, and results, according to the proposed methodology for systematic 
reviews of observational studies by the Moose (Meta-analysis Of Observational Studies 
in Epidemiology) group [80].
Search strategy
A comprehensive search was performed on EMBASE (1993–2011), Medline (1966–2011), 
and the Cochrane Library. The search strategy is outlined in Figure 7.1. The reference lists 
of each of the studies were manually inspected to find additional relevant studies.
#1 hip arthroplasty
#2 hip replacement
#3 #1 OR #2
#4 inflammatory arthritis
#5 rheumatoid arthritis
#6 #4 OR #5
#7 #3 AND #6
Figure 7.1 Database search strategy, words searched for in titles or abstracts.
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Inclusion criteria were: (1) clinical and radiological studies on cemented THA in RA 
patients. Exclusion criteria were: (1) studies including revision cases, (2) studies containing 
previously published data, (3) studies on other diagnoses than rheumatoid arthritis, 
(4) studies on other implants than conventional total hip arthroplasty (e.g. bipolar 
hemiarthroplasty and resurfacing hip arthroplasty), (5) studies other than clinical studies 
such as reviews, retrieval studies, case reports and expert opinions. 
To ensure that all relevant literature on cementless total hip arthroplasty in rheumatoid 
arthritis patients was accounted for, and to minimize publication bias, there were no 
limitations on study quality, language of publication or year of publication.
Data extraction
The information retrieved from each study included study design, sample size, patient 
characteristics, implants used, follow-up duration, definition of outcome measures and 
data analysis. The derived data included the incidence of infection, dislocation and aseptic 
loosening of cup and stem. 
Quality appraisal in relation to research questions
To create a level of transparency in the quality of the studies, quality appraisal was 
performed on ten items selected out of the previously described quality appraisal methods 
[23, 68, 74]. These were: (1) Study design: did the study design meet the requirements of 
our research question? (2) Prospective or retrospective study; (3) Homogeneity concerning 
type of implant; (4) Homogeneity concerning patient population: RA patients only or 
inclusion of patients with different types of inflammatory arthritis? (5) Transparency of 
inclusion criteria; (6) Transparency of outcome measures and assessment; (7) Sample size: 
defined as years that hips were at risk of failure, calculated by multiplying the number of 
included hips by the years of follow-up, whereby 100 hip years was chosen as arbitrary 
minimum; (8) Transparency of missing data and loss to follow-up; (9) Appropriate data 
management and statistics in relation to our research questions; (10) Declaration on 
conflicts of interest.
When no information was available for a potential bias, or if the method for addressing 
the bias was deemed inadequate, the item scored negative. An item scored positive when 
a serious attempt was made to minimize this risk of bias. A positive score did not mean 
that this potential bias was absent, nor did it imply that the techniques that were used to 
minimize bias were state-of-the-art.
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Statistical methods
To compare the results of the studies, failure was calculated as ‘failure rate per 100 years 
of hips at risk’. ‘Years of hips at risk’ was calculated as the number of hips in the study 
multiplied by the mean follow-up time. The failure rate was calculated as the number of 
failures divided by ‘years of hips at risk’ multiplied by 100. The NICE criteria (National 
Institute of Clinical Excellence) were used as a reference [57, 85]. According to these 
criteria, survival at ten years should be at least 90%. Calculated as the failure rate per 100 
‘years of hips at risk’, this represents a failure rate of 1 or less.
Results
Search
Results of the search are summarized in Figure 7.2. After screening of the abstracts 56 
studies matched the search criteria. After close examination, 26 of these were excluded: six 
studies did not differentiate between RA and osteoarthritis (OA) or studied another type 
of inflammatory disease [12, 13, 15, 38, 47, 89], two studies contained revision cases [30, 
Figure 7.2 PRISMA Flow chart.
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65], nine studies were on prostheses other than routinely used hip arthroplasties, such as 
bipolar hemiarthroplasties or resurfacing prostheses [3, 4, 10, 25, 72, 77, 83, 86, 90]. One 
study proved to be a review article [28], and one study reported on one-stage bilateral 
THA only [1]. Seven studies were excluded due to overlap of patient material. The studies 
with the longest follow-up were included. The studies of Welch and Charnley [87], Joshi 
et al. [33] and, Sochart et al. [76] report on the results from Wrightington Hospital (UK), 
on same patient material later published by Wroblewski et al. [94]. Colville and Raunio 
[17], Carlsson et al. [14], Poss et al. [60], and Kinzinger et al. [39] reported results on same 
population as respectively Lehtimäki et al. [46], Onsten et al. [58], Poss et al. [61], and 
Rosenberg et al. [66]. Overlap of patient material was found in two other studies. In the 
study by Arnold et al. [5] and Schule et al. [71], the results of a prospective multicentre 
comparative study were published in two separate articles. For our analysis their data were 
combined and the articles were treated as one study.
The twenty-one case series included are listed in Table 7.1, the scores for the items for 
quality appraisal in Table 7.2. The eight articles based on implant registries are listed in 
Table 7.3.
Infection
Six out of seventeen case series reported infection rates of 2% or more. 
The Swedish register reported a relative risk of 1.4 (95% CI 1.0–1.9, p = 0.04) for revision 
due to infection in RA compared to OA [29].
The Norwegian register reported a relative risk of 0.3 (95% CI 0.04–2.4, p = 0.3) for revision 
due to infection in RA compared to OA [26]. Using the Norwegian registry, Schrama et 
al. [70] evaluated the risk of revision for infection in primary hip and knee arthroplasty 
in patients with RA. The cumulative relative risk in the first five years compared to OA 
was 0.98 (95% CI 0.65–1.48), p = 0.94. However, after six years, a statistically significantly 
higher risk of revision for infection was seen in RA compared to OA: 4.1 (95% CI 1.6–11, 
p = 0.004).
The Finnish register reported a revision rate of 0.7% for infection in RA patients 55 years 
of age or younger [24] and 0.4% in RA patients older than 55 years of age [48].
The Danish register reported no specific information on infections. The relative risk of 
revision for any reason RA compared to OA was 0.8 (95% CI 0.65–1.01, p = 0.07) [67].
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Dislocation
Three out of seven case series report dislocation rates of 3% or more: Creighton et al. 
[20] reported 11% dislocations with a lateral approach with trochanteric osteotomy and 
complete capsulectomy. Lack et al. [43] reported 3.3% with a transgluteal approach without 
trochanteric osteotomy and, Wroblewski et al. [94] 3% with a transtrochanteric approach.
No data on dislocation rates were obtained from the registries as they reported on revisions 
and re-operations and not on closed reductions.
Aseptic loosening cup
Ten out of twenty case series reporting aseptic loosening rates showed increased loosening 
rates of the cup compared to the NICE criteria (Table 7.4).
The Swedish register did not differentiate between cup and stem survival. The survival 
rates for THA with stratification for age and gender, RA versus OA at 10 years with aseptic 
loosening as endpoint: men < 55 years: 84% versus 78% resp., 55–64 years: 90% versus 81% 
resp., 65–74 years: 93% versus 87% resp., and > 75 years: 100% versus 93% resp. Women 
< 55 years: 83% versus 79% resp., 55–64 years: 93% versus 88% resp., 65–74 years: 95% 
versus 92% resp., and > 75years: 96% versus 96% resp. [49]. The relative risk of aseptic 
loosening of THA in RA compared to OA: 1.1 (95% CI 1.0–1.2, p = 0.2) [29].
The Norwegian register reported a relative risk of cup revision for aseptic loosening in 
RA compared to OA: 1.2 (95% CI 0.4–3.3, p = 0.7) [26].
The Finnish register reported 10 years cup survival with aseptic loosening as endpoint 
in RA patients < 55 years: 91% (95% CI 89–94) [24], and in RA patients > 55 years: 94% 
(95% CI 93–95) [48].
The Danish register reported a relative risk of cup revision for aseptic loosening at 14 years 
RA compared to OA: 1.14 (CI 0.77–1.68) [67].
Aseptic loosening stem
Six out of nineteen case series reporting aseptic loosening rates showed increased loosening 
rates of the stem compared to the NICE criteria (Table 7.4).
The Swedish register did not differentiate between cup and stem. Survival rates for THA 
are mentioned above in the section on cup survival.
The Norwegian register reported a relative risk of stem revision for aseptic loosening in 
RA compared to OA: 1.1 (95% CI 0.6–2.0, p = 0.7) [26].
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Table 7.2 Quality appraisal according to customized 10 point scale
First author and year of 
publication 1.
 S
tu
dy
 d
es
ig
n
2.
 P
ro
sp
ec
tiv
e
3.
 U
ni
fo
rm
 im
pl
an
t
4.
 U
ni
fo
rm
 p
at
ië
nt
 p
op
ul
at
io
n
5.
 S
el
ec
tio
n 
cr
ite
ria
6.
 O
ut
co
m
e 
as
se
ss
m
en
t
7.
 S
am
pl
e 
si
ze
8.
 A
tt
rit
io
n 
bi
as
/L
os
t t
o 
FU
9.
 S
ta
tis
tic
s
10
. C
O
I
To
ta
l s
co
re
1 Ranawat 1980  [63]           5
2 Stauff er 1982 [79]           4
3 Johnsson 1984 [32]           5
4 Poss 1984 [62]           5
5 De Smet 1985 [75]           2
6 Lack 1986 [43]           5
7 Ranawat 1986 [64]           2
8 Unger 1987 [84]           5
9 Sarmiento 1990 [69]           4
10 Lakatos 1991 [44]           2
11 Severt 1991 [73]           3
12 Onsten 1994 [58]           8
13 Creighton 1998 [20]           7
14 Wessinghage 1998 [88]           7
15 ARO (Arnold & Schule 1998 [5])           6
16 Lehtimaki 1999 [46]           7
17 Rosenberg 2000 [66]           6
18 Tang 2001 [82]           3
19 Berry 2002 [7]           9
20 Matewski 2005 [51]           5
21 Wrobleski 2007 [94]           7
FU, follow-up; COI, confl ict of interest; , positive score; , negative score
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The Finnish register reported 10 years stem survival with aseptic loosening as endpoint 
in RA patients < 55 years: 90% (95% CI 88–92) [24], and in RA patients > 55 years: 96% 
(95% CI 94–97) for cemented loaded tapered stems and 92% (95% CI 90–94) for cemented 
composite-beam stems [48].
The Danish register reported a relative risk of stem revision for aseptic loosening at 14 
years RA compared to OA: 0.54 (95% CI 0.32–0.92) [67].
Discussion
Validity of data
This review was conducted as transparently as possible according to a methodology 
described by several authors [23, 50, 53, 74, 80, 92]. Our customized list is based on ten 
items used in other instruments but simplified to enable a quality appraisal and not a 
quantified appraisal. Thirteen of the twenty-one studies had less than six items scored as 
positive. An analysis of the results of the quality appraisal clearly reveals that the quality 
of most studies is poor and that the results of the studies are potentially subject to all 
kinds of bias.
Infection
Patients with RA are generally considered to be more prone to infection, due to the nature 
of the disease and the treatment with traditional disease-modifying anti-rheumatic drugs [6, 
18, 21, 27]. The subject of this review was whether this increased baseline risk of infections 
in RA leads to increased joint infection rates after THA. However, the results of this review 
are conflicting, as one-third of the case series and half of the registries reported increased 
infection rates. Any evaluation must take into account that underestimation of infection 
rates could have occurred in both types of studies. The case series used could result in 
an under-registration of the infection rate due to the poor quality of the studies, with a 
potential risk of bias due to incomplete data, short follow-up, etcetera.
For their part, the arthroplasty registries could result in an underestimate of the infection 
rates as only the revisions due to infection are included and not the re-operations with 
wash-out and retention of the prosthesis. It is possible that infections occurring in the first 
post-operative years were treated with wash-out procedures - and thus not recorded - and 
that infections that occurred in later post-operative years were treated with revisions (as 
pointed out by Schrama et al. [70]). Bongartz et al. [8] reported an infection rate of 3.7% 
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in a study on 657 hips and knee replacements in patients with RA. The authors concluded 
that RA patients have an increased risk of infection after total joint arthroplasty. However 
patients with previous surgery, previous infection and revision surgery were included. The 
infection rate in the 164 primary THA in RA patients was 1.2%.
It has to be concluded that investigation of infection rates is complex due to the low 
incidence rates and multi-factorial causation and that this review does not produce 
convincing evidence for increased infection rates in RA patients. However, we believe that 
despite these limitations, in light of the relatively frequent reports of increased infection 
rates in combination with the potential of under-registration, RA patients have a mildly 
increased risk of post-operative infection after THA compared to OA patients.
Dislocation
The risk of dislocation after THA is influenced by many factors. There are patient-related 
factors such as old age [9, 22, 56], female gender [36, 91], prior hip surgery [22, 59, 91] 
and surgical factors such as posterior approach [52, 41, 91] and femoral head diameter 
[11]. Besides the difficulties identifying a single factor as an independent risk factor for 
dislocation, within this multivariate relationship there is another major problem: obtaining 
reliable data [31]. As most dislocations are treated with closed reduction, retrospective 
studies analysing hip scores, revisions, radiographs and survival without specifically 
searching for the incidence of dislocation will not produce reliable data. Several other 
studies have been published analysing RA as a risk factors for dislocation. Khatod et al. 
[37] analysed dislocation rates in 1970 THAs including 44 primary THA in RA patients. 
The dislocation rate was 9% (4 hips) in the RA group and 1.2% (14 hips) in the OA group. 
Univariate and multivariate analysis showed a 6 fold greater risk of dislocation in the RA 
group. Kita et al. [40] analysed 252 THAs. The dislocation rate was 11.1% in primary RA 
THAs and 1.1% in primary OA THAs (exact numbers were not available). Multivariate 
analysis showed that the dislocation rate was 13 times greater in RA. Zwartelé et al. [95] 
analysed 410 primary THAs including 70 inflammatory arthritis patients. The dislocation 
rate was 10.0% (7 hips) in the IA group and 2.9% (10 hips) in the OA group. Multivariate 
analysis showed a 3.7 fold greater risk of dislocation in the RA group.
It has to be concluded that this review of case series and registries cannot answer the 
question of whether RA is a risk factor for dislocation, but based on other reports, we 
believe that RA has to be considered as an independent risk factor for dislocation after 
primary THA.
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Cup survival
Eight of the ten case series that reported increased failure rates due to aseptic loosening 
were based on series predominantly implanted before 1980. None of the registries have 
reported significantly increased rates of aseptic loosening, all registries are based on data 
of THAs predominantly implanted after 1980. These findings show that the success rate 
of cup survival has improved over the years and that the differences between cup survival 
in RA and OA have diminished. Apart from new implants and new cementing techniques 
[54], several factors contributed to this success: firstly, operation techniques have been 
developed to deal with protrusio acetabuli resulting in improved outcomes [66]. Secondly, 
THA is being performed in an earlier phase of the disease process, as there is evidence that 
postponing surgery for too long will provide less functional results [55]. Thirdly, THA is 
now mostly performed as a primary operation and not as a secondary procedure due to 
the fact that osteotomies, synovectomies, hemi-cup-arthroplasties or other procedures are 
outdated [16, 19]. Fourthly, a new generation of drugs makes RA a less mutilating disease 
of the joints [45]. In conclusion, although there used to be an increased risk of cup failure 
due to aseptic loosening in RA patients compared to the NICE criteria (and compared to 
cup failure in OA patients and stem failure), there is no evidence that the risk of aseptic 
loosening of the acetabular component is increased in RA patients today.
Stem survival
All case series that reported increased failure rates due to aseptic loosening were based on 
series predominantly implanted before 1980. None of the registries have reported significant 
increased rates of aseptic loosening, all are based on data of THAs predominantly implanted 
after 1980. The reasons for this improvement were discussed in the section on cup survival. 
These findings show that the success rate of stem survival has improved over the years 
and that there is no evidence that the risk of aseptic loosening of the femoral component 
is increased in RA patients.
Conclusions
The quality of the case series on THA in RA is poor and arthroplasty registries are not 
suited to deliver information on infection and dislocation rates. 
However, we believe that despite these limitations, in light of the relatively frequent reports 
of increased infection rates in combination with the potential under-registration of infection 
rates in the included studies, RA patients have a mildly increased risk of post-operative 
infection after THA in comparison with OA patients.
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This review of case series and registries does not answer the question of whether RA is 
a risk factor for dislocation. However, based on reports not included in the review using 
multi-variate analysis, we believe that RA has to be considered as an independent risk 
factor for dislocation after primary THA.
Although there used to be an increased risk of cup failure due to aseptic loosening in 
RA patients compared to the NICE criteria (and compared to cup failure in OA patients 
and stem failure), there is no evidence that the risk of aseptic loosening of the acetabular 
component is increased in RA patients today.
The success rate of stem survival has improved over the years and there is no evidence that 
there is an increased risk of aseptic loosening of the femoral component among RA patients.
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Abstract
Background: Compromised rheumatic bone is a potential risk factor for mechanical 
complications in cementless total hip arthroplasty (THA) in cases of rheumatoid arthritis 
(RA). Increased rates of intra-operative fractures, component migration and (early) aseptic 
loosening are to be expected. Despite this, cementless THA is performed in cases of RA.
Methods: A literature search on cementless THA in RA was performed in EMBASE 
(1993–2011), Medline (1966–2011) and the Cochrane Library. A systematic review was 
conducted with a special emphasis on mechanical complications. 
Results: Twenty-three case series and five studies of implant registries were included. 
Acetabular fractures and/or migration of the cup were reported in 9 out of 22 studies of 
the cup. Proximal femoral fractures and/or subsidence of the stem were reported in 14 out 
of 20 studies of the stem. Six studies compared failure rates of uncemented and cemented 
components due to aseptic loosening. The overall failure rate ratio (uncemented/cemented) 
for the cup was 0.6 (95% CI: 0.14–2.60) and for the stem 0.71 (95% CI: 0.06–8.55), both 
favoring uncemented fixation. The failure rates in case series without a control group 
were compared to the NICE criteria (failure rate/1). The overall failure rate for the cup 
was 0.97 (95% CI: 0.50–1.88) and for the stem 0.79 (95% CI: 0.44–1.41). Failure rates of 
aseptic loosening of higher than 1 (favoring cemented fixation) were reported in 6 out of 
26 studies of the cup and in 2 out of 25 studies of the stem. In all these studies, the inferior 
implant designs were blamed, and not the type of fixation or the quality of the bone.
Conclusions: Despite substantial rates of mechanical stem complications, no evidence was 
found to establish that cementless components perform less well than cemented compo-
nents. The results justify the use of cementless THA in RA patients. 
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Introduction
Rheumatoid arthritis (RA) strongly affects the properties of bone [1, 3, 42], while in 
addition bone metabolism is influenced by the intake of medication by RA patients [54, 
59]. The compromising biomechanical changes in rheumatic bone could increase the risk 
of mechanical complications in cementless implants, such as peri-prosthetic fractures, 
insufficient initial implant stability and insufficient osseous integration causing early 
implant failure.
This systematic literature review was conducted to investigate the results of uncemented 
total hip arthroplasty (THA) in RA patients, with a special emphasis on mechanical 
complications. The research questions formulated were: (1) What are the rates of early 
complications such as intra-operative, peri-prosthetic fractures, implant migration and 
early loosening? (2) What are the failure rates with aseptic loosening as end point compared 
to cemented implants in RA patients, or compared with the criteria of the National Institute 
of Clinical Excellence (NICE) [41]?
Methods
The systematic review was performed using methodology and checklists on search strategy, 
methods and results, according to the proposed methodology for systematic reviews 
of observational studies by the meta-analysis of observational studies in epidemiology 
(MOOSE) group [51].
Search strategy
A comprehensive search was performed on EMBASE (1993–2011), Medline (1966–2011) 
and the Cochrane Library. Search terms used were ‘cementless OR uncemented AND hip 
arthroplasty AND RA’. The reference lists of each of the studies were manually inspected 
to find additional relevant studies.
Inclusion criteria were: (1) clinical studies on cementless THA in RA patients in comparison 
with cemented THA, and (2) clinical studies on cementless THA in RA patients with other 
than a cemented control group or no control group. Exclusion criteria were: (1) studies 
including revision cases, (2) studies containing previously published data, (3) studies 
without rheumatoid patients, (4) studies on other implants than conventional THA (e.g., 
resurfacing hip arthroplasty), (5) studies other than clinical studies such as reviews, 
radiological and retrieval studies, case reports and expert opinions.
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To ensure that all relevant literature on cementless THA in RA patients was accounted for, 
and to minimize publication bias, there were no limitations on study quality, language of 
publication or year of publication.
Data extraction
Data were extracted by one of the investigators (first author) and checked for accuracy 
by a second investigator (second author). The information retrieved from each study 
included study design, sample size, patient characteristics, implants used, follow-up 
duration, definition of outcome measures and data analysis. The derived data included 
the incidence of intra-operative fractures and post-operative migration of components not 
defined as loose. The time from initial operation to revision was recorded. Early loosening 
was defined by the authors of the reports as aseptic loosening in an early phase following 
the initial operation. Failure events were described as any revision for aseptic loosening 
of cup or stem, or radiographical loosening as defined by the authors.
Quality appraisal in relation to research questions
To create a level of transparency in the quality of the studies, quality appraisal was performed 
on ten items selected out of previously described quality appraisal methods [13, 45, 47, 
61]. These were: (1) study design – whether the study design met the requirements of 
our research question, for example a comparative study with cemented THA as control 
group or a case series without control group; (2) prospective or retrospective study; (3) 
homogeneity concerning type of implant; (4) homogeneity concerning patient population 
– RA patients only or inclusion of patients with different types of inflammatory arthritis; 
(5) transparency of selection criteria for cementless THA; (6) transparency of outcome 
measures and assessment; (7) sample size, defined as years that hips were at risk of failure, 
calculated by multiplying the number of included hips by the years of follow-up, whereby 
100 hip years was chosen as the arbitrary minimum; (8) transparency of missing data and 
loss to follow-up; (9) appropriate data management and statistics in relation to our research 
questions; (10) declaration of conflicts of interest. 
The same investigators as mentioned earlier scored the items. Any disagreements were 
resolved by consensus. When no information was available for a potential bias, or if the 
method for addressing the bias was deemed inadequate, the item scored negative. An item 
scored positive when a serious attempt was made to minimize this risk of bias. A positive 
score did not mean that this potential bias was absent, nor did it imply that the techniques 
that were used to minimize bias were state of the art.
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Statistical methods
To compare the results between the studies, failure was calculated as ‘failure rate per 
100 years of hips at risk’. ‘Years of hips at risk’ was calculated as number of hips in the 
study multiplied by the mean follow-up time. The failure rate was calculated per group 
(cementless/cemented) in comparative studies. In the absence of a control group in the 
case series, the NICE criteria (National Institute of Clinical Excellence) were used as a 
reference [41]. According to these criteria, survival at 10 years should be at least 90%. 
Calculated as the failure rate per 100 ‘years of hips at risk’, this represents one failure per 
100 years. The confidence intervals for the failure rates of exactly 95% were based on the 
Poisson distribution. The random effects meta-analysis to obtain the overall failure rate 
of a number of case series was based on a random intercept Poisson model [49]. For the 
comparative studies, the groups were compared by calculating the failure rate ratio as the 
failure rate in the cementless group divided by the failure rate in the cemented group. 
The corresponding exact confidence intervals were based on the binominal distribution. 
The random effects meta-analysis to obtain the overall failure rate ratio of a number of 
comparative studies was based on the random intercept logistic regression model with 
offset variable, as described by Stijnen et al. [49]. The meta-analysis models were fitted 
using SAS NLMIXED version 9.2. All other analyses were carried out in STATA version 11.
Results
Search
Initially, 37 studies matched the search criteria. After close examination, nine of these were 
excluded: one article appeared to be a comment on another study [56], two studies included 
only juvenile chronic arthritis patients [18, 30], two studies contained revision cases [10, 23] 
and another two studies were on prostheses other than routinely used hip arthroplasties 
such as cementless polyethylene cups [35] and resurfacing prostheses [43]. Overlap of 
patient material was found in two other studies. In the study by Arnold et al. [2] and Schule 
et al. [46], the results of a prospective multicenter comparative study were published in two 
separate articles. For our analysis, their data were combined and the articles were treated as 
one study. In the study by Effenberger et al. [11] and Effenberger et al. [12], part of the patient 
material was used twice. Only the data from the first publication were used for the analysis.
The 28 included studies are listed in Table 8.1 together with the scores of the items used for 
quality appraisal. Three groups of studies were formed for both cup and stem separately: 
comparative studies (comparison between cementless and cemented components in RA), 
case series without control group, and registers (reports of national implant registers).
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Acetabular component outcome
Acetabular fractures (Table 8.2): four studies reported acetabular fractures in 2–5%. Three 
of these studies concerned perforations of the acetabular floor by threaded cups [2, 48, 
62], and the fourth study reported two acetabular rim fractures by a press-fit design [63]. 
All these fractures were treated conservatively, and none caused failure of the implant.
Migration (Table 8.2): six studies reported migrated cups, three of which reported rates 
of 10% or more [8, 28, 34].
Early loosening (Table 8.2): five studies reported early loosening. Dominkus et al. [8] 
reported three loose cups after an average period of 31 months. Zwartelé et al. [62] reported 
that two cups were loosened within 2 years after implantation. The three other studies 
reported single cases of early loosening [63, 25, 55].
Aseptic loosening (Table 8.2; Figures 8.1, 8.2): Table 8.2 shows the failure rates for aseptic 
loosening per 100 years of ‘hips at risk’. Six studies reported failure rates higher than one 
Figure 8.1 Comparative studies of cup. Failure rate of cementless cups compared to cemented 
cups. A ratio of 1 means no difference between the groups, more than 1 means higher failure 
rate for cementless cups and vice versa. Random effects Poisson model calculated overall as 
described in the text.
119
Chapter 8Review on cementless THA in RA
(the NICE criteria) [2, 11, 25, 27, 36, 37]. Figure 8.1 displays the results of the comparative 
studies with the ratio of failure between cementless and cemented cups. A ratio of more 
than one occurred in two studies [2, 16] and indicated a worse outcome for the cementless 
cup. The overall failure rate ratio for the cup was 0.6 (95% CI: 0.14–2.60), In the study 
by Glusevicz et al. [16], the failure rate of cementless cups was higher compared to the 
cemented cups but low compared to the NICE criteria (0.5, see Table 8.2). This result was 
not judged as poor. Figure 8.2 displays the results of the case series. The failure rates in 
case series without control group were compared to the NICE criteria (failure rate/1). The 
overall failure rate for the cup was 0.97 (95% CI: 0.50–1.88).
The results of the four studies based on national arthroplasty registries are summarized in 
Table 8.3. In the Finnish Arthroplasty Register, the results of press-fit porous coated cups 
after 10 years in RA equaled the results of cemented cups in RA in patients younger than 
55 years [14]. Smooth threaded cups performed poorly. In a separate report based on the 
Finnish registry on patients older than 55 years, uncemented cups performed better than 
cemented ones [38]. Poorly performing implants were excluded from the analysis. In the 
Swedish register, commonly used cementless cups perform better than commonly used 
cemented cups in the general population [19]. Sub-analysis for RA was not performed. 
Figure 8.2 Case series of cup. Failure rate of cementless cups in relation to the NICE criteria. A 
ratio of more than 1 means a higher rate of failure than the minimal NICE criteria.
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In the Danish registry, the cumulative risk for revision for aseptic loosening after 14 years 
was slightly higher for RA than for osteoarthritis (OA) [44]. Sub-analysis for cementless 
THA was not performed.
Femoral component outcome
Femoral fractures (Table 8.2): nine studies reported femoral fractures. All reported fractures 
could be classified as type A according to the Vancouver classification [9], i.e., avulsions 
of the tip of the trochanter or calcar fissures. In all reported cases, conservative treatment 
or intra-operative direct fixation was performed, and none caused failure of the implant.
Subsidence (Table 8.2): ten studies reported subsidence. In the study by Smilowicz et al. 
[48], the subsidence rate was as high as 80%. Despite this high subsidence rate, only 5 out 
of the 56 subsided stems were found loose after a mean follow-up of 14 years, resulting 
in a failure rate of 0.3. In the other nine studies, only one stem was found loose due to 
aseptic loosening [57].
Early loosening (Table 8.2): early aseptic loosening was reported once [22]. 
Aseptic loosening (Table 8.2; Figures 8.3, 8.4): Table 8.2 displays the failure rates per 100 
years of ‘hips at risk’ compared to the NICE criteria. Two studies reported increased failure 
rates [22, 53]. In the report by Hoikka et al. [22], failure of one stem led to a failure rate of 
2.5 due to the small study population and the short follow-up time. This was not judged 
as a poor result. Figure 8.3 displays the results of the comparative studies with the ratio 
of failure between cementless and cemented stems. A ratio of more than one occurred 
in two studies [2, 53] and indicated a worse outcome of the cementless stem. The overall 
failure rate ratio (uncemented/cemented) for the stem was 0.71 (95% CI: 0.06–8.55). In 
the study by Arnold et al. [2], the failure rate of cementless stems was higher compared 
to cemented stems, but low compared to the NICE criteria (0.4. See Table 8.2). This was 
not judged as a poor result.
Figure 8.4 displays the results of the case series. The failure rates in case series without 
control group were compared to the NICE criteria (failure rate/1). The overall failure rate 
for the stem was 0.79 (95% CI: 0.44–1.41). 
Table 8.4 summarizes the results of the five studies based on national arthroplasty registries. 
The studies on the Finnish register show better results for cementless stems both in young 
and in older patients with RA [14, 38]. In the studies on the Norwegian [20] and Swedish 
[19] registries, cementless stems performed well in the general population irrespective of the 
diagnosis. Sub-analysis for RA was not performed. In the Danish registry, the cumulative 
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Figure 8.3 Comparative studies of stem. Failure rate of cementless stems compared to 
cemented stems. A ratio of 1 means no difference between the groups, more than 1 means 
higher failure rate for cementless stems and vice versa. Random effects Poisson model calculated 
overall as described in the text.
Figure 8.4 Case series of stem. Failure rate of cementless stems in relation to the NICE criteria. 
A rate of more than 1 means a higher rate of failure than the minimal NICE criteria.
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risk for revision for aseptic loosening after 14 years was slightly higher for OA than for 
RA [44]. Sub-analysis for cementless THA was not performed.
Discussion
Compromised biomechanical properties of rheumatic bone, caused by inflammatory 
diseases and medication, are potential risk factors for a positive end result of THA in 
RA patients. This leads to many questions with regard to the practice of implanting 
cementless components in rheumatic bone. In the last three decades, several studies 
have been published on cementless THA in RA patients. The results of these articles 
were assessed to gain insight into the rates of intra-operative, peri-prosthetic fractures 
and early complications caused by insufficient initial stability or insufficient osseous 
integration. The results show that cementless cups are rarely associated with mechanical 
complications, while cementless stems result in an increased risk of intra-operative, peri-
prosthetic proximal femoral fractures and subsidence. Despite these complications, no 
well-documented evidence was found that established that cementless components were 
associated with increased rates of aseptic loosening in RA patients. These findings suggest 
that initial implant stability and osseous integration are sufficient, despite the altered 
biomechanical properties of the rheumatic bone.
Validity of data
This review was conducted as transparently as possible according to a methodology 
described by several authors [13, 39, 40, 47, 51, 60]. Many instruments have been developed 
for assessing the methodological quality of non-randomized studies [6]. The Newcastle–
Ottawa Scale [58] is recommended in the Cochrane Handbook for systematic reviews of 
interventions [21], but in this specific situation this scale did not lead to a transparent 
and simple quality appraisal. Our customized list is based on ten items used in other 
instruments, but simplified to enable a quality appraisal and not a quantified appraisal. 
Of the 28 studies, 15 had less than six positive scored items, and only 2 studies scored 
more than seven positive items. Upon analysis of the results of the quality appraisal, it 
is obvious that the quality of most studies is poor and that the results of the studies are 
potentially subject to all kinds of bias. Despite these limitations – and the great variation 
in the included studies with respect to methodology, patient population, implants used, 
year and location of conduct, and quality – the results are quite uniform, as only a few, 
mostly explainable, deviations were found.
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Interpretation of acetabular component outcome
Acetabular fractures: intra-operative peri-prosthetic acetabular fractures are rare, especially 
when press-fit cups are used. All fractures were treated conservatively and none caused 
implant failure.
Migration: six studies report on migrated cups, three of them in more than 10% of the cups. 
Migration is said to be a predictor of component failure [29] On the other hand, limited 
early migration could be a seating effect of cementless cups without having consequences 
on the outcome. Due to the limited follow-up time, it is not possible to distinguish between 
these two mechanisms.
Early aseptic loosening: early aseptic loosening is rare. Increased rates of early aseptic 
loosening was reported twice, both in studies with the threaded Zweymuller cup [8, 62]. 
The long-term results of both studies were excellent.
Aseptic loosening: six studies showed poor results of cementless cups in RA, one 
comparative study [2] and five case series [11, 25, 27, 36, 37]. In five of these studies 
with poor result, the smooth threaded cup design was blamed. High failure rates of these 
designs are confirmed by several studies with OA patients [4, 7, 17]. In the sixth study 
with poor results [27], the hemispherical cup design was blamed, the cause being wear 
of the polyethylene caused by a thin liner as described earlier in OA patients [24]. The 
Finnish register accounted for these poor performing components and made sub-analysis 
for different types of designs. They concluded that in young patients with RA, the results 
of the cementless cups were as good as the results of cemented ones [14], while in older 
patients the results of cementless cups were better than those of cemented cups [38].
Interpretation of femoral component outcome
Femoral fractures: a majority of the studies reported intraoperative, peri-prosthetic 
fractures. All fractures were type A fractures and could be treated conservatively or with 
cerclage wires. There were no reports of late peri-prosthetic fractures caused by a fall or 
major trauma. These latter fractures (when classified as type B or C) are known to be a major 
mode of failure of uncemented stems [19, 32, 50]. Irrespective of the diagnosis, implantation 
of cementless stems seems to be associated with an increased risk of periprosthetic fractures.
Subsidence: subsidence is reported frequently in a majority of the studies, but does not 
seem to be a predictor of implant failure, as the failure rates of cementless stems were low 
even in studies with high subsidence rates. 
Early aseptic loosening: early aseptic loosening was rarely reported.
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Aseptic loosening: poor results due to aseptic loosening of the stem were reported in one 
study [53]. The authors blamed this high failure rate on the first-generation cementless 
stem design. All other studies reported good results of the cementless stems in RA.
Conclusions
Despite the poor quality of most studies, the results were quite uniform, as only a few, 
mostly explainable, deviations were found. Cementless cups are rarely associated with 
mechanical complications. Cementless stems have substantial risks on intra-operative, peri-
prosthetic proximal femoral fractures, and subsidence. No evidence, which established that 
well-documented cementless components were associated with increased rates of aseptic 
loosening in RA patients, was found. These findings suggest that initial implant stability 
and osseous integration are sufficient despite the altered biomechanical properties of the 
rheumatic bone. The results justify the use of cementless THA in RA patients. Whether 
this conclusion will last in the long run has to be confirmed by awaited long-term studies. 
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Due to a new generation of anti-rheumatic biologicals a decreasing rate of RA related 
surgery has been reported in the last decade [2, 3, 6, 7]. When eventually medicinal 
treatment fails, surgical intervention is indicated. Cemented THA has been the treatment of 
choice in end-stage hip disease since its introduction in the nineteen sixties and seventies. 
THA in RA is frequently associated with increased complication rates such as postoperative 
infections, dislocation of the prostheses, and periarticular fractures. Loosening of the cup 
has been the considered the weakest link for a successful long-term outcome. In the hope to 
improve the long-term results uncemented THA was introduced in the nineteen eighties. 
With this thesis we wanted to assess if cementless implants can be used safely in total hip 
arthroplasty in rheumatoid patients, and to assess if the use of cementless implants could 
be beneficial for the rheumatoid patient.
The first research question if we can develop a finite element computer model to investigate 
the relationship between the biomechanical properties of bone and the fixation of 
cementless implants, proved to be more difficult than expected. To develop such a model 
to simulate press-fit fixation with different biomechanical properties of the bone several 
assumptions regarding the biomechanical properties of the bone had to be incorporated. To 
which account these data reflect the actual situ situation is insecure. For example, poor bone 
quality resulting from RA was represented in the FEA models by a 50 percent reduction of 
the local bone stiffness. Although these results indicate that this has a significant effect on 
the results, it is not possible to verify the accuracy of the input data, due to a lack of data 
on the mechanical properties of rheumatoid bone. In addition, to the authors’ knowledge 
no data have been reported on experiments with press-fit acetabular cups implanted 
in rheumatoid subchondral bone that could further validate the modelling approach. 
Furthermore, plasticity was introduced to the subchondral bone in order to provide a 
more realistic representation of the actual bone material behaviour. Unfortunately, no 
data are currently available to validate whether the plastic behaviour simulated in these 
models is in the range of the actual plastic deformations occurring in the subchondral 
bone. However, it was found that adding bone plasticity has a considerable effect on the 
interfacial mechanics. Consequently, the current finite element analysis (FEA) models 
had some limitations with regards to bone material properties, and interfacial parameters.
The results show that different ways of fixation were found for the flattened cup with polar 
clearance, and the hemispherical implant designs. While the hemispherical cup displayed 
a larger area of contact, the cup with a polar clearance had higher contact stresses, which 
were mainly concentrated at the peripheral rim. These findings are in line with other 
studies on flattened cups. A study with a three-dimensional photoelastic model showed 
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that loading a hemispherical cup increases load transfer in the dome and decreases load 
transfer at the rim. With a non-hemispherical cup, peripheral stresses remained higher 
under increasing load than dome stresses. The authors suggested that there may be less 
press-fit stability of the hemispherical cup with increasing load and that initial stability 
is better with a non-hemispherical geometry [4]. In a cadaver study, stress distributions 
were compared between natural hip joints and a flattened and a hemispherical cup [8]. 
The natural hip joint showed high stresses in the rim of the acetabulum, mainly in the 
ischial, iliac, and pubic facets, and low stresses in the dome. This distribution was similar 
with the flattened cup, while the hemispherical cup showed non-physiological contact 
between the pole of the cup and the dome of the acetabulum. 
In the situation with poor bone quality, our FEA model showed that the cup with polar 
clearance and interference fit of 2 mm provided the highest lever-out force with maximal 
contact stresses at the rim. However, in this situation the interfacial micromotions increased 
(more than 500 μm), at the pole and locally at the rim, thus perturbing bone ingrowth 
at these sites [5]. As long as bony ingrowth at the other contact area is not disturbed the 
FEA model shows that in the situation with poor bone quality the flattened cup with high 
interference fit provides sufficient physiological rim fixation.
The second research question was on the results of cementless cup designs and a cementless 
stem in RA patients compared to OA patients in our own institute, with special emphasis 
on peri-operative fractures, component migration and aseptic loosening. 
In the first clinical study several complications occurred more frequently in the RA group: 
perforation of the threaded cup through the acetabular floor and malposition of the cup 
in a too cranial position. Together with the two traumatic fractures of the acetabulum 
with tilting of the cup in the RA group and the increased rate of avulsions of the tip of 
the greater trochanter, these findings suggest a tendency for a higher rate of fractures in 
RA patients caused by the altered mechanical properties of the rheumatoid bone. The 
fractures of the tip of the trochanter will be related to the increased stresses on the gluteal 
muscle while the leg is exorotated and adducted during a trans-gluteal approach. Also, an 
increased rate of bone atrophy in the acetabulum and the proximal femur was found in 
the RA group compared to the OA group. 
The second clinical study on the flattened cup shows that the risk of fractures of the 
acetabulum does not seem to be a significant problem. However, after 6–10 years, failure 
of the cup occurred four times; once due to aseptic loosening and three times due to 
osteolysis. The failures were related to additional factors such as an acetabular defect, 
malposition of the cup and unstable inserts, but none of these failures did occur in the OA 
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group. The initial gap between the dome of the acetabulum and the cup filled itself rapidly 
with trabecular bone during the process of osseous integration. It seems that as long as 
acetabular bone stock is sufficient and positioning of the cup is adequate loosening of the 
cup can be prevented in both the diagnostic groups. 
In answer to the third research question on the results in the literature of cemented THA 
in RA, with special emphasis on infection, dislocation and aseptic loosening it has to be 
concluded that the quality of the literature on cemented THA in RA is often poor. Evaluation 
of studies reporting infection must take into account that underestimation of infection 
rates could have occurred. Case series could result in an underestimation of the infection 
rate due to the poor quality of the studies, with a potential risk of bias due to incomplete 
data, short follow-up, etcetera. For their part, arthroplasty registries could result in an 
underestimation of the infection rates as only the revisions due to infection are included 
and not the re-operations with debridement and retention of the prosthesis. However, 
despite the limitations of the conducted review, and considering the relatively frequent 
reports of increased infection rates in combination with the potential underestimation 
of infection rates in the included studies, RA patients have to be considered to have a 
mild – but potentially dangerous – increased risk on post-operative infection after THA 
compared to OA patients. 
The same risk of underreporting counts for the risk on dislocation and is supported by 
the findings of the prospective clinical study presented in this thesis on dislocation rates 
of THA in RA that clearly suggest that inflammatory arthritis has to be considered as an 
independent risk factor for dislocation after primary THA.
Studies from the period before nineteen eighty reported increased rates of aseptic loosening 
of cemented components in RA. However, the rates of aseptic loosening of cup and stem in 
recent studies in RA showed no evidence of a significant increased risk of aseptic component 
failure. These findings show that the success rate of cup survival has improved over the 
years and that the differences between cup survival in RA and OA have diminished. Apart 
from new cementing techniques and improved quality of polyethylene cups, several factors 
contributed to this success: firstly, operation techniques have been developed to deal with 
protrusio acetabuli resulting in improved outcomes. Secondly, THA is being performed 
in an earlier phase of the disease process, as there is evidence that postponing surgery for 
too long will provide less functional results. Thirdly, THA is now mostly performed as 
a primary operation and not as a secondary procedure due to the fact that osteotomies, 
synovectomies, hemi-cup-arthroplasties or other procedures are outdated. Fourthly, thanks 
to the new generation of drugs in most cases the joints are less mutilated as before.
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In answer to the fourth research question on the results of cementless THA in RA in the 
literature with special emphasis on peri-operative fractures, migration, aseptic loosening 
and dislocation it has to be concluded that the literature on cementless THA is scarce and 
that the quality is often poor. Despite the poor quality of most studies, the results were 
quite uniform, as only a few, mostly explainable deviations were found. Cementless cups 
are rarely associated with mechanical complications. Cementless stems have substantial 
risks on intra-operative, peri-prosthetic proximal femoral fractures, and subsidence. No 
evidence was found which established that well-documented cementless components were 
associated with increased rates of aseptic loosening in RA patients. 
In conclusion
The finite element model shows that in a situation with poor bone quality, the flattened cup 
with high interference fit provides sufficient physiological rim fixation in the acetabulum. 
The fixation of the hemispherical cup is based on a non-physiological larger contact area 
between the pole of the cup and the dome of the acetabulum. 
The first two clinical studies and the review study on cementless THA in RA show that 
despite altered biomechanical properties of rheumatoid bone, mechanical stability and 
osseous integration of cementless prostheses are not compromised. However, cementless 
stems are associated with increased rates of mechanical complications. The third clinical 
study shows that RA has to be considered as a risk factor for dislocation.
The review study in cemented THA in RA shows that aseptic loosening of the cup used 
to be the limited factor for long-term survival but recent studies report excellent survival 
of both cemented cup and stem. Overall it can be stated that the quality of most studies 
on cemented and uncemented THA in RA is poor. The risk on post-operative infection 
and dislocation seems to be increased in RA.
The increased rates of mechanical complications, especially on the femoral side, suggest 
that some concerns on cementless THA in RA are being confirmed. However, these types 
of complications are not specific for RA patients as they are reported in OA patients with 
cementless THA as well [1]. Considering this similarity with the OA population it seems 
that the discussion whether to use cemented or uncemented components in RA patients 
is not about the quality of the bone but about the quality of the prostheses. Before it can 
be stated that cementless implants are the treatment of choice for the rheumatoid (and the 
osteoarthritis) patient, improvement of long-term survival compared to cemented THA 
will have to outweigh the increased complication rate.
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Chapter 1 is the introduction. The aim of the thesis is presented: to assess if cementless 
implants can be used safely in total hip arthroplasty in rheumatoid patients, and to assess 
if the use of cementless implants could be beneficial for the rheumatoid patient.
To investigate the aims of this thesis four research questions were formulated: (1) can we 
make a computer model to investigate the relationship between biomechanical properties 
of bone and fixation of cementless implants, and can we predict which type of fixation type 
is best in relation with the quality of the bone? (2) What are the results of cementless cup 
designs (threaded and press-fit) and a cementless stem in RA patients compared to OA 
patients in our own institute, with special emphasis on four mechanical complications: 
peri-operative fracture, component migration, aseptic loosening and dislocation? (3) What 
are the results in the literature of cemented THA in RA? (4) What are the results in the 
literature of cementless THA in RA?
Chapter 2 gives an overview of demographics of hip involvement in rheumatoid arthritis 
(RA), history of surgical treatment, technical considerations on hip replacement and 
potential complications facing hip arthroplasty in rheumatoid arthritis patients. 
Standard cemented THA has been for many years the treatment of choice in destructive hip 
disease in RA. Patients with RA are generally considered to be more prone to complications 
after hip replacement due to the nature of the disease with its deleterious effects on the bone 
and soft tissues, and due to the side effects of anti-rheumatic drug treatment. Perioperative 
management includes cautiousness for cervical spine instability, management of anti-
rheumatic medication, and preoperative surgical planning to prevent malpositioning of 
implants. Timing of the operation is the key to success in RA surgery.
Chapter 3 reports the results of investigations with a finite element computer model of 
the pelvis on the fixation strength of press-fit cups in relationship to the quality of the 
acetabular bone and the geometry of the cup. In addition, the effects of interference fit, 
friction and implant material were analyzed. Cups were introduced into an FEA model of 
a human pelvis with simulated subchondral bone plasticity. The models were loaded with 
a loading configuration simulating two cycles of normal walking, during which contact 
stresses and interfacial micromotions were monitored. Subsequently, a lever-out simulation 
was performed to assess the fixation strength of the various cases.
The results show that different ways of fixation were found for the non-hemispherical, 
flattened cup with polar clearance, and the hemispherical implant designs. The cup with 
a polar clearance had higher physiological contact stresses at the peripheral rim. The 
fixation of the hemispherical cup is based on a non-physiological larger contact area 
between the pole of the cup and the dome of the acetabulum. In the situation with poor 
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bone quality, the model showed that the cup with polar clearance and interference fit 
of 2 mm provided the highest lever-out force with maximal contact stresses at the rim. 
However, in this situation the interfacial micromotions increased (more than 500 μm), at 
the pole and locally at the rim. 
In chapter 4 the long-term results of a retrospective clinical study are presented. The 
study was performed in The Slotervaartziekenhuis in Amsterdam, a reference centre for 
inflammatory arthritis patients. Cementless THA in RA patients is being performed here 
since 1986. The results of cementless THA in RA patients are compared to the results of 
the same prostheses in OA patients.
The aim of this study was to assess the outcome of primary cementless total hip arthroplasty 
in rheumatoid arthritis patients and to compare the results with osteoarthritis patients. 
Sixty-four patients (77 hips) with rheumatoid arthritis and 120 patients (135 hips) with 
osteoarthritis with a conical-shaped Zweymueller threaded cup and a tapered, rectangular 
Zweymueller stem were assessed after an average of 12.5 years. The endpoints for survival 
analysis were failure of one or both components due to radiographic loosening or revision. 
Revision was defined as exchange of cup, stem or both. When the PE-insert or the ceramic 
ball head were exchanged leaving cup and stem in place, e.g. for PE-wear or dislocation, this 
was not considered a revision but a re-intervention. No differences were found in survival 
rates; however, in the rheumatoid arthritis group there was an increased rate of malposition of 
the cup, avulsions of the greater trochanter, and increased bone resorption in the trochanteric 
region. This study shows that despite altered biomechanical properties of rheumatoid bone, 
mechanical stability and osseous integration of cementless prosthesis are not compromised 
and, although a higher complication rate did occur, long-term survival is excellent. 
In chapter 5 a second clinical study from The Slotervaartziekenhuis is presented. In this 
study the results of a new type of press-fit acetabular components were analyzed in a 
prospective study again with a comparison between cementless THA in RA and OA 
patients.
A flattened cup was designed to create a more physiological load transfer to the pelvic 
bone com- pared to hemispherical cups, and to allow more bone con- tact compared to 
low-profile’ spherical cups. To investigate these theoretical advantages and the potential 
influence of the quality of the acetabular bone, a clinical study was per- formed in patients 
with osteoarthritis (OA) and inflammatory arthritis (IA). The aims of the study were (1) to 
evaluate the fixation of the cup, postoperatively and later when osseous integration should 
have taken place, (2) to assess perioperative complications such as acetabular fractures 
and (3) to monitor the polar gap, a potential risk factor for osteolysis. 
144
SummaryChapter 10
A prospective study was performed on all consecutive OA and IA patients with an indication 
for primary total hip arthroplasty (THA). Three hundred and nine OA patients (340 hips) 
and 65 IA patients (76 hips) were included. The acetabular component was the flattened 
press-fit EPF-PLUS® cup, the femoral component the tapered cementless Zweymueller SL-
PLUS® stem. All revisions and complications were recorded. Clinical and radiographical 
evaluation was performed on regular basis during 6–10 years. 
The incidence of early loosening of the cup was 0 out of 340 in the OA group and 1 out 
of 76 in the IA group. The incidence of acetabular fractures was 7 out of 340 in the OA 
group and 3 out of 76 in the IA group. Failure rate for the acetabular component due to 
aseptic loosening or osteolysis after 6–10 years was 0% in the OA group and 4.8% in the IA 
group. In all cases available for follow-up the polar gap had disappeared and full osseous 
integration had taken place in both the groups. 
This study shows that the flattened press-fit acetabular component creates adequate initial 
mechanical stability to allow osseous integration and that the cup can be safely used in 
both OA and IA patients. However, after 6–10 years, in the IA group failure of the cup 
due to aseptic loosening occurred once and failure due to osteolysis occurred three times, 
while these type of failures did not occur in the OA group. 
In chapter 6 a third clinical study is presented; a prospective study to analyze the alleged 
increased risk on post-operative hip dislocation in RA patients compared to OA patients. 
We carried out a prospective study assessing the incidence of dislocation within 2 years 
after surgery for patients diagnosed with inflammatory arthritis (IA) and osteoarthrosis 
(OA). One single type of prosthesis was implanted using a lateral approach. Both diagnostic 
groups were compared by univariate analysis with respect to dislocation, sex, age, diagnosis, 
prior hip surgery, experience of the surgeon and malposition of the acetabular component. 
In a multivariate logistic regression approach, the difference in dislocation incidence was 
assessed after adjusting for the effect of the potential confounders given above. Between 
1996 and 1999, 410 THA were performed: 70 in IA and 340 in OA. After 2 years no 
patients were lost to follow-up, but 12 patients had died, and 5 revisions were carried out 
for reasons other than dislocation.
The dislocation rate in patients with IA was higher than in patients with OA: 10% (7 hips) 
in the IA group and 3% (10 hips) in the OA group (p = 0.006). No significant differences 
were found among the risk factors for dislocation between the two groups. Multivariate 
logistic regression analysis showed that IA is an independent risk factor for dislocation 
(odds ratio (OR) 3.7, 95% CI 1.3–-11), together with malposition of the cup in more than 
55 degrees abduction (OR 7.7, CI 2.3–26) and increased ant version (OR 7.6, CI 1.4–42.4).
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Our findings clearly suggest that inflammatory arthritis has to be considered as an 
independent risk factor for dislocation after primary THA.
Chapter 7 is a review of the literature on cemented THA in RA focused on infections, 
dislocation and aseptic loosening of cup and stem. Twenty-one case series and eight reports 
on four implant registries were included. The quality of most studies was poor.
The reported rates of infection and dislocation were conflicting in the case series and 
the arthroplasty registries proved unsuitable for providing reliable data. There is a risk of 
underestimation of incidences in both types of studies.
Increased rates of aseptic loosening were reported in ten out of twenty case series on 
the cup and in six out of nineteen on the stem (when compared to the criteria of the 
National Institute of Clinical Excellence (NICE)). Nearly all of these were based on series 
implanted before 1980. None of the registries reported a significantly increased risk of 
aseptic loosening of cup or stem. 
Despite the limitations of this review, and considering the relatively frequent reports of 
increased infection rates in combination with the potential underestimation of infection 
rates in the included studies, and taking into account the results of other reports, we believe 
that RA patients have a mild increased risk of post-operative infection and dislocation 
after THA compared to OA patients.
Although there used to be an increased risk of cup and stem failure due to aseptic loosening 
in RA patients, there is no evidence that this increased risk is still significant today.
Chapter 8 is a systematic review on the literature on cementless THA in rheumatoid 
arthritis with special emphasis on complications such as peri-operative fractures, implant 
migration, aseptic loosening and survival.
Twenty-three case series and five studies of implant registries were included. Acetabular 
fractures and/ or migration of the cup were reported in 9 out of 22 studies of the cup. 
Proximal femoral fractures and/or subsidence of the stem were reported in 14 out of 
20 studies of the stem. Six studies compared failure rates of uncemented and cemented 
components due to aseptic loosening. The overall failure rate ratio (uncemented/
cemented) for the cup was 0.6 (95% CI: 0.14–2.60) and for the stem 0.71 (95% CI: 
0.06–8.55), both favoring uncemented fixation. The failure rates in case series without 
a control group were compared to the NICE criteria (failure rate/1). The overall failure 
rate for the cup was 0.97 (95% CI: 0.50–1.88) and for the stem 0.79 (95% CI: 0.44–1.41). 
Failure rates of aseptic loosening of higher than 1 (favoring cemented fixation) were 
reported in 6 out of 26 studies of the cup and in 2 out of 25 studies of the stem. In all 
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these studies, the inferior implant designs were blamed, and not the type of fixation or 
the quality of the bone. 
Despite substantial rates of mechanical stem complications, no evidence was found to 
establish that cementless components perform less well than cemented components. The 
results justify the use of cementless THA in RA patients. 
Chapter 9 is the general discussion. The finite element computer model shows that in 
a situation with poor bone quality, the flattened cup with high interference fit provides 
sufficient physiological rim fixation in the acetabulum. The fixation of the hemispherical 
cup is based on a non-physiological larger contact area between the pole of the cup and 
the dome of the acetabulum. 
The first two clinical studies and the review study on cementless THA in RA show that 
despite altered biomechanical properties of rheumatoid bone, mechanical stability and 
osseous integration of cementless prostheses are not compromised. However, cementless 
stems are associated with increased rates of mechanical complications. The third clinical 
study shows that RA has to be considered as a risk factor for dislocation.
The review study in cemented THA in RA shows that aseptic loosening of the cup used 
to be the limited factor for long-term survival but recent studies report excellent survival 
of both cemented cup and stem. Overall it can be stated that the quality of most studies 
on cemented and uncemented THA in RA is poor. The risk on post-operative infection 
and dislocation seems to be increased in RA.
The increased rates of mechanical complications, especially on the femoral side, suggest 
that some concerns on cementless THA in RA are being confirmed. However, these types 
of complications are not specific for RA patients as they are reported in OA patients with 
cementless THA as well. Considering this similarity with the OA population it seems that 
the discussion whether to use cemented or uncemented components in RA patients is 
not about the quality of the bone but about the quality of the prostheses. Before it can be 
stated that cementless implants are the treatment of choice for the rheumatoid (and the 
osteoarthritis) patient, improvement of long-term survival compared to cemented THA 
will have to outweigh the increased complication rate.
Samenvatting
Ongecementeerde heupprotheses bij rheumatoïde arthritis
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In hoofdstuk 1 wordt het doel van het proefschrift beschreven: bepalen of ongecementeerde 
heupprotheses veilig kunnen worden gebruikt bij patiënten met rheumatoïde arthritis en 
of deze ongecementeerde protheses wellicht voordelen hebben voor rheumapatiënten. 
Om dit te onderzoeken zijn vier vraagstellingen geformuleerd: (1) is het mogelijk om 
met behulp van een computermodel de relatie te onderzoeken tussen de biomechanische 
eigenschappen van bot en de fixatie van ongecementeerde implantaten, en zo ja, kunnen we 
dan de beste ongecementeerde fixatiemehode identificeren in verhouding tot de kwaliteit 
van het bot? (2) Wat zijn de resultaten van ongecementeerde cups (zowel schroefcups 
als pressfit cups) en een ongecementeerde steel geplaatst bij patiënten met rheumatoïde 
arthritis in vergelijking tot arthrosepatiënten, met speciale aandacht voor vier mechanische 
complicaties: peri-operatieve fracturen, migratie van componenten, aseptische loslating 
en luxatie? (3) Wat zijn de resultaten in de literatuur van gecementeerde heupprotheses 
bij rheumapatiënten? (4) Wat zijn de resultaten in de literatuur van ongecementeerde 
heupprotheses bij rheumapatiënten?
Hoofdstuk 2 geeft een overzicht van de demografie van heupproblematiek bij rheumapa-
tiënten, de geschiedenis van chirurgische behandeling, de technische overwegingen en de 
potentiële complicaties bij heupvervanging.
De reguliere gecementeerde heupprothese is jarenlang de eerste keus geweest bij secundaire 
coxarthrose op basis van rheumatoïde arthritis. Een verhoogd risico op complicaties 
gerelateerd aan de operatie wordt beschouwd als gevolg van de effecten van het ziekteproces 
op het bot en de weke delen, en van de negatieve bijverschijnselen van de anti-rheumatische 
medicijnen. Peri-operatieve maatregelen bevatten alertheid op cervicale instabiliteit, zo 
nodig aanpassen van de rheumamedicatie, en preoperatieve chirurgische planning ter 
preventie van malpositie van implantaten. Timing van de operatie wordt beschouwd als 
de sleutel tot succes.
Hoofdstuk 3 beschrijft de resultaten van metingen met een ‘eindig elementen’ computer-
model van het bekken. De sterkte van de fixatie van press-fit cups in het acetabulum 
werd bepaald in relatie met de vorm van de cup en de kwaliteit van het bot. De effecten 
van ‘interference fit’ (maatvoering), wrijving en materiaaleigenschappen van cup en bot 
werden geanalyseerd. Het model simuleerde twee loopcycli ten tijde waarvan contactstress 
en microbewegingen tussen cup en bot werden gemeten. De fixatiesterkte van de cup werd 
bepaald door een ‘lever-out’ test.
De resultaten toonden dat cups die niet hemisferisch zijn – maar afgeplat ter hoogte van de 
pool – een ander fixatiemechanisme hebben dan hemisferische cups. De niet-hemisferische 
cups verkrijgen press-fit fixatie door hogere contactstress ter hoogte van de periferie 
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van het acetabulum zoals in de fysiologische situatie. De hemisferische cups verkrijgen 
fixatie door een groter contactoppervlak tussen cup en acetabulum. In de situatie met 
verminderde botkwaliteit wordt de sterkste fixatie verkregen met een niet-hemisferische 
cup met 2 mm interference fit. In deze situatie is de contactstress in de acetabulaire rand 
het hoogst, maar zijn de microbewegingen ter hoogte van de pool en ook lokaal aan de 
rand verhoogd (meer dan 500μm).
Hoofdstuk 4 bevat de resultaten van een retrospectieve klinische studie verricht in het 
Slotervaartziekenhuis te Amsterdam. De vakgroep orthopedie is gespecialiseerd in 
rheumatologische orthopedie en plaatst sinds 1986 ongecementeerde heupprotheses 
bij rheumapatiënten. De resultaten van deze groep patiënten werden vergeleken met 
arthrosepatiënten die in dezelfde periode dezelfde prothese geplaatst hadden gekregen. 
Er werden 77 heupprotheses geplaatst bij 64 rheumapatiënten en 135 protheses bij 120 
arthrosepatiënten. De prothese betrof de Zweymüller konische schroefcup in combinatie 
met de Zweymüller-steel. De gemiddelde ‘follow-up’ bedroeg 12½ jaar. Het eindpunt voor 
de analyse van de overleving van de prothese was radiologische loslating of revisie van 
één of beide componenten. Revisie was gedefiniëerd als cup- of steelwissel. Als de cup 
en/of de steel niet werden gewisseld en alleen de insert en/of de kop werden gewisseld 
voor polyethyleenslijtage of instabiliteit, werd dit niet als revisie maar als reïnterventie 
gekwalificeerd.   
De resultaten toonden geen verschil in overleving, maar in de rheumagroep bleek er 
een hogere incidentie te zijn van malpositie van de cup, van avulsiefracturen van de tip 
van het trochanter en van botresorptie in de trochanterregio.  De studie toonde aan dat, 
ondanks de aangetaste eigenschappen van het rheumatische bot, mechanische stabiliteit 
van de implantaten en botingroei in de implantaten voldoende zijn om goede overleving 
te kunnen bereiken, maar dat er meer complicaties zijn dan in de arthrosegroep. 
In hoofdstuk 5 wordt een tweede studie uit het Slotervaartziekenhuis gepresenteerd. In 
deze prospectieve studie werden de klinische resultaten van een nieuw type press-fit cup 
vergeleken tussen rheuma- en arthrosepatiënten, net als in de studie van hoofdstuk 4.
De nieuwe cup was ontworpen met een afgeplatte pool om een meer fysiologische over-
dracht van krachten te creëren naar de periferie van het acetabulum in vergelijking met 
een hemisferische cup die ook overdracht van kracht geeft aan de pool. Om verlies van 
botcontact te beperken werd alleen de pool afgeplat in tegenstelling tot de ‘low profile’ 
sferische cups. Doelstellingen van de klinische studie waren: (1) evaluatie van de fixatie van 
de cup postoperatief en later wanneer botingroei plaats zou moeten hebben gevonden. (2) 
Vastleggen van perioperatieve complicaties zoals acetabulaire fracturen. (3) Beoordeling van 
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de ontwikkeling van de ruimte tussen de pool van de cup en de bodem van het acetabulum 
– de zogenoemde ‘polar gap’ –, een potentiële risicofactor voor osteolyse.
Alle opeenvolgende patiënten met inflammatoire arthritis en arthrose met een indicatie voor 
een primaire heupprothese werden geïncludeerd: 76 heupprotheses in 65 rheumapatiënten 
en 340 protheses in 309 arthrosepatiënten. Alle patiënten kregen dezelfde heupprothese: 
de cup zoals hierboven beschreven (EPF-PLUS®) in combinatie met de de ongecemeteerde 
Zweymüller SL-PLUS® steel. Alle revisies en complicaties werden geregistreerd. Klinische 
en radiologische controle werd gedurende 6 tot 10 jaar verricht.
De resultaten toonden geen enkele vroege aseptische loslating in de arthrosegroep en 
één in de rheumagroep. De incidentie van acetabulaire fracturen was 7 van de 340 in de 
arthrosegroep en 3 van de 76 in de rheumagroep. Het percentage aseptische loslating 
van de cup na 6 tot 10 jaar was 0% in de arthrosegroep en 5% in de rheumagroep. In alle 
gevallen bleek de ‘polar gap’ verdwenen en was er appositie van bot aan het oppervlak van 
de cup.
De studie toonde dat afgeplatte cups voldoende stabiliteit creëren om botingroei te verkrijgen 
en dat de cup veilig kan worden gebruikt zowel bij arthrose- als bij rheumapatiënten. Echter, 
na 6 tot 10 jaar waren er vier cups in de rheumagroep die moesten worden gereviseerd; 
één in verband met aseptische loslating en drie in verband met osteolyse. Deze problemen 
traden niet op in de arthrosegroep.
In hoofdstuk 6 wordt een derde klinische studie gepresenteerd; een prospectieve studie 
naar het vermeende verhoogde risico op heupluxaties na THP bij rheumapatiënten. Een 
groep rheumapatiënten en een groep artrosepatiënten werd tot 2 jaar na het plaatsen 
van een primaire THP vervolgd. Er werd gebruik gemaakt van één type prothese en één 
type benadering (transgluteaal). Er werden zeventig protheses in de rheumagroep en 340 
in de arthrosegroep vervolgd. In de rheumagroep bleken significant meer heupluxaties 
voor te komen dan in de arthrosegroep: 10% (n = 7) versus 3% (n = 10), p = 0.006. Met 
behulp van univariate analyse en multivariate logistische regressieanalyse werd het effect 
van verschillende potentiële confounders onderzocht: geslacht, leeftijd, diagnose, eerdere 
heupchirurgie, ervaring van de chirurg, en malpositie van de cup. Hieruit bleek dat rheuma 
een onafhankelijke risicofactor is voor luxatie van de prothese net als malpositie van de 
cup in te veel abductie (> 55 graden) en malpositie in te veel anteversie (respectievelijk 
odds ratio (OR) 3,7, 95% CI 1,3–1,1; OR 7,7, 95% CI 2,3–26; OR 7,7, 95% CI 1,4–42,4).
Hoofdstuk 7 is een review van de literatuur over de resultaten van gecementeerde heup-
protheses bij rheumapatiënten met speciale aandacht voor infecties, luxaties, en aseptische 
loslating. Er werden 28 artikelen geïncludeerd; 21 case series en 8 artikelen met de resultaten 
151
Samenvatting
van 4 verschillende landelijke implantatenregisters. De kwaliteit van de meeste studies 
was matig. 
De case series toonden tegenstrijdige incidenties van infecties en luxaties. De resultaten 
van de landelijke registers bleken geen bruikbare incidentiegegevens op te leveren voor 
deze complicaties. 
Een verhoogd risico op aseptische loslating van de cup werd gevonden in 10 van de 20 
case series en van de steel in 6 van de 19. Bijna alle studies met verhoogde incidenties van 
aseptische loslating betroffen studies met protheses die vòòr 1980 waren geïmplanteerd. 
Geen van de registers vond een verhoogd risico op aseptische loslating van gecementeerde 
heupprotheses bij RA-patiënten.
De review geeft geen duidelijkheid over het risico op postoperatieve infecties en luxaties na 
THP bij rheumapatiënten. Desondanks menen wij dat rheumapatiënten een hoger risico 
hebben voor deze complicaties omdat het risico op onderrapportage van de complicaties bij 
beide studietypes zeer aannemelijk is. Wat betreft het risico op aseptische loslating tonen 
de recente artikelen geen duidelijk verhoogd risico in de rheumapopulatie, in tegenstelling 
tot de oudere studies.
Hoofdstuk 8 is een systematische review van de literatuur over de resultaten van ongece-
menteerde heupprotheses bij rheumapatiënten met speciale aandacht voor complicaties 
zoals peri-operatieve fracturen, migratie van implantaten en aseptische loslating. 
Er werden 28 studies geïncludeerd; 23 case series en 5 studies met de resultaten van 4 
verschillende landelijke implantatenregisters. Acetabulaire fracturen en/of cupmigratie 
werd gerapporteerd in 9 van de 22 studies over de cup. Proximale femorale fracturen 
en/of steelinzakking werd gerapporteerd in 14 van de 20 studies over de steel. Om de 
resultaten van de verschillende studies te kunnen vergelijken werd het aantal gefaalde 
protheses berekend als faalratio per 100 jaar heupen ‘at risk’. Hiertoe werd per studie het 
aantal protheses vermenigvuldigd met de gemiddelde follow-up-duur. Het aantal gefaalde 
heupen werd gedeeld door dit getal en vermenigvuldigd met 100. 
Zes studies vergeleken de resultaten van ongecementeerde protheses met gecementeerde 
protheses. Het faalratio van de prothese ten gevolge van aseptische loslating uitgedrukt in 
de vergelijking ongecementeerd/gecementeerd bleek zowel voor de cup als voor de steel 
gunstiger voor de ongecementeerde protheses (cup: OR 0,6, 95% CI 0,14–2,60; steel: OR 
0,71, 95% CI 0,06–8,55). Voor de case series zonder controlegroep werden de faalratio’s 
vergeleken met de NICE-criteria voor de overleving van heupprotheses (maximaal 
faalpercentage van 10 na 10 jaar) uitgedrukt in de vergelijking faalratio/1. In alle studies 
tezamen was dit voor de cup 0,97 (95% CI 0,50–1,88) en voor de steel 0,79 (95% CI 0,44–
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1,41). Faalratio’s van meer dan 1 werden gevonden in 6 van de 26 studies voor de cup en 
in 2 van de 25 studies voor de steel. In al deze studies met verhoogde faalratio’s werden 
inadequate implantaten als oorzaak van het falen bestempeld en niet de fixatiemethode 
of de verminderde botkwaliteit.
Ondanks de frequente meldingen van mechanische complicaties van de ongecementeerde 
steel en in mindere mate van de ongecementeerde cup werden er geen bewijzen gevonden 
dat de overleving van ongecementeerde implantaten minder goed is dan van gecementeerde 
implantaten. Op basis hiervan wordt geconcludeerd dat het gebruik van ongecementeerde 
protheses bij rheumapatiënten gerechtvaardigd is.
In hoofdstuk 9 worden alle bevindingen samengevat en bediscussieerd. Het eindige 
elementen computermodel toont dat in de situatie met verzwakt bot de afgeplatte cup 
fixatie verkrijgt door in te klemmen in de rand van het acetabulum. Deze vorm van fixatie 
is natuurlijker dan de fixatie van de hemisferische cup die fixatie verkrijgt door een groter 
contactoppervlak, onder andere in de bodem van het acetabulum. 
De eerste twee klinische studies en de literatuurstudie over ongecementeerde protheses 
bij rheumapatiënten laten zien dat de stabiliteit van de ongecementeerde implantaten 
voldoende is, ondanks de veranderde biomechanische eigenschappen van het rheumatische 
bot. Wel worden er meer mechanische complicaties van de steel gemeld. 
De literatuurstudie over gecementeerde heupprotheses bij rheumapatiënten toont dat de 
overleving van de prothese van oudsher beperkt werd door aseptische loslating van de 
cup. Recente studies tonen echter prima overlevingsresultaten van zowel cup als steel. De 
kwaliteit van de studies is echter beperkt. 
Duidelijkheid over de incidentie van infecties en luxaties wordt met de reviewartikelen 
niet verkregen. Er zijn verschillende oorzaken die het uitblijven van duidelijkheid kunnen 
verklaren. Ten eerste komen de complicaties weinig voor (als het goed is bij minder dan 
5% van de patiënten) waardoor grote studiepopulaties nodig zijn om betrouwbare analyses 
uit te voeren. Vrijwel alle studies ontberen de benodigde aantallen, en het poolen van de 
data is niet mogelijk als gevolg van de te grote verscheidenheid van de populaties zoals case 
mix, operatietechnieken, implantaten, en lokale behandelprotocollen. Ten tweede bestaat er 
een reëel risico op onderrapportage van de incidenties ten gevolge van de studiemethodes 
in de artikelen. Mede gezien het laatste punt menen wij dat het risicio op infectie na een 
heupprothese verhoogd is bij rheumapatiënten. In hoofdstuk 6 wordt duidelijk gemaakt 
dat rheumatoïde arthritis een onafhankelijke risicofactor is voor luxatie. 
De verhoogde incidentie van mechanische complicaties van de ongecementeerde steel ten 
opzichte van de gecementeerde steel wordt ook gezien bij arthrosepatiënten en is niet uniek 
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voor rheumapatiënten. Gezien de resultaten van de studies en de vergelijkbaarheid van de 
resultaten met arthrosepatiënten lijkt het er op dat de discussie niet behoort te gaan over 
de kwaliteit van het bot, maar over de kwaliteit van de prothese. Lange-termijnresultaten 
dienen uit te wijzen of een langere overleving van ongecementeerde implantaten opweegt 
tegen een verhoogd complicatierisico.
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